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Abstract  
 
The methylotrophic yeast Pichia pastoris is an established eukaryotic expression 
system for the production of heterologous proteins of biopharmaceutical or 
industrial interest, due to its stable cheap production processes and the good protein 
secretion abilities. Endoplasmic reticulum (ER)-resident or secretory heterologous 
protein production usually leads to an unfolded protein response (UPR), through 
augmented level of chaperones such as Kar2, and to formation of reactive oxygen 
species (ROS). To improve product titers in an efficient manner, cellular stress 
responses before and after methanol-induced recombinant proteins production has 
to be attended in a comprehensive way. Monitoring the main UPR marker Kar2 
during the defined medium glycerol growth batch phase, allowed the identification 
of a sudden and strong ~20 fold downregulation of this ER-resident chaperone 
from exponential growth phase to stationary phase. High Kar2 levels in 
exponentially growing cells were observed in culture media with initial glycerol 
concentrations ranging from 30 to 125 g/L and were suggested to be caused due to 
an overlapped effect of high osmolarity and high specific growth rates. 
Additionally, high Kar2 levels prior to methanol induction presented no positive 
correlation with the secretory Insulin precursor (IP) production assessed by 
inducing the cells at different glycerol batch time points. Although no clear relation 
between UPR prior induction and product titer was identified, intracellular and 
extracellular Kar2 was produced exclusively due to recombinant protein production 
since after induction no Kar2 was detected in either fraction of the control host 
strains. Furthermore, methanol induction of Pichia pastoris IP producing cells at 
stationary growth phase resulted in the highest amounts of de novo synthesized 
Kar2 and, under industrial relevant bioreactor conditions, increasing methanol 
concentrations applied during fed-batch hastened the chaperone secretion. Further 
results pointed out to a positive correlation of recombinant protein production and 
augmented ROS levels during the methanol fed-batch phase and to an 
independence of phase of glycerol growth at induction time and ROS levels for the 
secretory IP producing strain. Moreover, cells presented high viability during the 
entire fed-batch process (> 93 %). A deeper comprehension of the nature of UPR is 
fundamental to improve P. pastoris strains performance in various biotechnological 
processes. Therefore, the herein presented results are a valuable contribution which 
could be used to guide general models for protein secretion and used for 
engineering design of new cell factories. 
Keywords: Komagataella (Pichia) pastoris, recombinant protein production, 
unfolded protein response  
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Zusammenfassung 
Die methylothrophe Hefe Pichia pastoris ist ein bewährtes eukaryotisches 
Expressionssystem für die Produktion von heterologen Proteinen, welche 
interessant für biopharmazeutische und industrielle Anwendungen sind, da dieses 
Expressionssystem einen stabilen und günstigen Produktionsprozess ermöglicht 
und gute sekretorische Eigenschaften besitzt. Die am endoplasmatischen Reticulum 
(ER) ansässige Proteinfaltung oder die sekretorische heterologe Proteinproduktion 
führen normalerweise zu einer ungefalteten Proteinantwort (unfolded protein 
response, UPR) durch eine erhöhten Spiegel an Chaperonen, wie Kar2, und auch 
zu der Bildung von reaktiven Sauerstoffspezies (reactive oxygen species, ROS). 
Um den Produkttiter effizient zu erhöhen, muss die zelluläre Stressantwort vor und 
nach der Methanol-induzierten rekombinanten Proteinproduktion umfassend 
betrachtet werden. Durch die Beobachtung des Hauptindikators für eine UPR, 
Kar2, während der Glycerin Batch-Wachstumsphase in definiertem Medium, 
konnte die plötzliche und sehr starke ca. 20-fache Herabregulation dieses ER-
ansässigen Chaperones beim Übergang der exponentiellen Wachstumsphase zur 
stationären Phase festgestellt werden. Ein hoher Kar2 Level in exponentiell 
wachsenden Zellen konnte in Kulturmedien mit einer Anfangsglycerin- 
konzentration von 30 bis 120 g/L beobachtet werden. Es wird angenommen, dass 
dieser hohe Kar2 Level auf einen überlappenden Effekt von hoher Osmolarität und 
hohen spezifischen Wachstumsraten zurückzuführen ist. Zusätzlich hat ein hoher 
Kar2 Spiegel vor der Induktion mit Methanol keine positive Korrelation mit der 
Produktion des sekretorischen Insulinvorläufers gezeigt, unabhängig davon zu 
welchem Zeitpunkt der Glycerin Batch-Phase die Zellen induziert wurden. 
Trotzdessen, dass keine Relation zwischen der UPR vor Induktion und des 
Produkttiters festgestellt wurde, trat intrazelluläres und extrazelluläres Kar2 nur 
aufgrund der rekombinanten Proteinproduktion auf, da nach Induktion Kar2 in 
keiner der Fraktionen des Kontrollwirtsstammes detektiert werden konnte. 
Desweiteren führte die Methanolinduktion von Insulinvorläufer produzierenden 
Pichia pastoris Zellen während der stationären Wachstumsphase zu der höchsten 
Menge an de novo synthetisiertem Kar2. Zudem hatte unter industriell relevanten 
Reaktorbedingungen eine erhöhte Methanolkonzentration während der Fed-Batch-
Phase eine beschleunigte Chaperonsekretion zur Folge. Weitere Ergebnisse lassen 
auf eine positive Korrelation zwischen rekombinanter Proteinproduktion und eines 
erhöhten Spiegels an ROS während der Methanol Fed-Batch Phase schließen. 
Zusätzlich lassen sie Rückschlüsse auf eine Unabhängigkeit des 
Induktionszeitpunktes während der Glycerin Wachstumsphase und der Menge der 
ROS im Produktionsstamm des sekretorischen Insulinvorläufers zu. Außerdem 
zeigten die Zellen eine hohen Viabilität (> 93 %) während des gesamten Fed-
Batch-Prozesses. Ein tiefgehendes Verständnis der Eigenschaften der UPR ist 
entscheidend um die Leistung des P. pastoris Stammes in den unterschiedlichsten 
biotechnologischen Prozessen zu verbessern. Aus diesem Grund sind die hier 
dargestellten Ergebnisse ein wertvoller Beitrag, der dazu genutzt werden kann, 
allgemeine Modelle für Proteinproduktion zu schaffen und zudem können die 
Erkenntnisse für eine konstruktive Entwicklung von sogenannten „cell factories“ 
genützt werden.    
Stichwörter: Komagataella (Pichia) pastoris, Rekombinante Proteinproduktion, 
ungefalteten Proteinantwort  
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1. Introduction 
 
Biopharmaceuticals are considered the future of the pharmaceutical industry. 
Nowadays, there are more than 300 biopharmaceutical products including 
therapeutic proteins and antibodies in the market with world sales exceeding USD 
165 billion in 2012, and growth expectation of 15 % per year. In Brazil, the 
Ministry of Health spends around USD 10 billion annually on these highly 
expensive imported products; even though this stands for ~45 % of the budget 
allocated to medicines, it represents only 5 % of the purchased drugs volume [1]. 
Due to governmental intervention, Brazil is willing to put up some of the financing 
to try to reduce its expenses for buying drugs by encouraging more domestic 
production of key biopharmaceuticals with patents about to expire. 
Along the last decades, improvements in the production of heterologous proteins 
have been achieved, however the strategies sometimes are strain and/or protein 
specific and cannot be generally implemented. The methylotrophic yeast Pichia 
pastoris is among the most favored microbial eukaryotic expression systems for 
production of recombinant proteins of biopharmaceutical or industrial interest, due 
to its stable cheap production processes and the good protein secretion abilities. To 
study the physiology of Pichia pastoris producing recombinant products in fed-
batch bioreactor cultures has been part of the group research focus for some years 
now [2-4]. The interest arises because there is limited knowledge existing on how 
stress responses during the production of proteins such as Insulin, vaccines or 
others are affecting the final productivities and the recombinant product quality. 
Furthermore, surprisingly little attention has been given to the yeast physiological 
state prior to induction, independent of the production of aberrant proteins. This 
work, therefore, aims for the interdisciplinary integration of strong science and 
robust technical excellence consolidated through international exchange, seeking to 
deepen the knowledge which underlies the sophisticated biopharmaceuticals 
production process. 
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2. Theoretical background 
 
In the first section of this work, topics which are required for a better general 
comprehension of the studied thesis are introduced. At first, a brief presentation, 
prevalence data and estimation of the chronic disease for which the recombinant 
protein here produced can be applied, as well as, a brief historical background, 
characterisation of the hormone itself and some market projections together with its 
research outlook. Thereafter, the microbiological platform in which the 
biopharmaceutical was produced is presented, jointly with some specific properties 
of the biotechnological process employed. Finally, the most relevant background 
for this work is presented – regulation of protein folding and stress responses. A 
general idea of the cellular folding process is presented, focusing afterwards in the 
specifics of the folding machinery and its regulation, stress due to heterologous 
protein production and the effect of the environment on cells.  
 
2.1. Diabetes 
 
The scientific term "diabetes mellitus" describes a metabolic disorder of multiple 
aetiology characterized by chronic hyperglycaemia with disturbances of 
carbohydrate, fat and protein metabolism resulting from defects in Insulin 
secretion, Insulin action, or both. Diabetes is a chronic disease that occurs either 
when the pancreas does not produce enough Insulin or when the body cannot 
effectively use the Insulin it produces. Insulin is a hormone that regulates blood 
sugar [5]. Hyperglycaemia, or raised blood sugar, is a common effect of 
uncontrolled diabetes and over time leads to serious damage to many of the body's 
systems, especially the nerves and blood vessels. 
In 2014 the global prevalence of diabetes was estimated to be 9% among adults 18 
years and older [6]. In 2012 diabetes was the direct cause of estimated 1.5 million 
deaths [7]. More than 80% of diabetes deaths occur in low- and middle-income 
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countries [7]. The World Health Organization projects that diabetes will be the 7th 
leading cause of death in 2030 [8]. 
There are two main types of diabetes. Type 1 diabetes (previously known as 
Insulin-dependent, juvenile or childhood-onset) is characterized by deficient 
Insulin production and requires daily administration of Insulin. The cause of type 1 
diabetes is not known and it is not preventable with current knowledge. Type 2 
diabetes (formerly called non-Insulin-dependent or adult-onset) results from the 
body’s ineffective use of Insulin. Type 2 diabetes comprises 90% of people with 
diabetes around the world [5], and is largely the result of excess body weight and 
physical inactivity. Other categories of diabetes include gestational diabetes (a state 
of hyperglycaemia which develops during pregnancy) and "other" rarer causes 
(genetic syndromes, acquired processes such as pancreatitis, diseases such as cystic 
fibrosis, and exposure to certain drugs, viruses, and unknown causes). Intermediate 
states of hyperglycaemia (impaired fasting glucose or impaired glucose tolerance) 
are conditions at high risk of progressing to type 2 diabetes. 
 
2.2. Insulin 
 
Insulin is produced by the pancreatic beta-cells essential for normal glucose 
homeostasis and therefore useful in treating diabetes. Insulin therapy is essential to 
the survival of those with type 1 diabetes and is used to control the 
symptoms/progression of a minority of those with the more commonly occurring 
type 2 diabetes. Projections estimate that by 2030 the global diabetes prevalence 
will lay around 328 million cases [8]. According to the latest market report the 
global Insulin market was valued at USD 19.99 billion in 2012 and is expected to 
grow at a geometric progression ratio of 6.1 % from 2013 to 2019 to reach USD 
32.24 billion in 2019 [9]. Novo Nordisk A/S (Denmark), Eli Lilly & Co. (USA) 
and Sanofi S.A. (France) represent the major global Insulin manufacturers. 
Insulin has become one of the most thoroughly studied molecules in scientific 
history. Such importance is exemplified by its involvement in several Nobel Prizes. 
The first one in 1923, was awarded jointly to Frederick Grant Banting and John 
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James Rickard Macleod "for the discovery of Insulin". Early commercial Insulin 
preparations were generally produced by an acid-alcohol precipitation of pancreatic 
extracts from slaughterhouse bovine and porcine animals. The initial preparations 
contained so many impurities, that the first patient treated with an injection of 
Insulin suffered severe allergic reaction. Successful purification occurred through 
the discovery of a zinc promoted Insulin crystallization [10], followed by a re-
crystallization step. This process allowed the production of highly pure animal 
Insulins called “conventional Insulins” which were commercialized for many 
years.  
The second Nobel Prize involving Insulin was the one in Chemistry awarded to 
Frederick Sanger in 1958. His work on the structure of proteins culminated with 
the first protein ever to be sequenced – bovine Insulin. In time, different animals 
had their Insulin sequence determined and it turned out that the amino acid 
sequence of Insulin is almost exactly the same for hundreds of different species, 
explaining the reason for successful application of animal Insulin in human in the 
early 1920’s. Looking at the enzyme in more detail, the sequence of porcine Insulin 
and human Insulin differ by one amino acid, whereas bovine Insulin is different by 
three amino acids from human (Figure 2.2.1). Human Insulin is a two-stranded 
hormone of 51 amino acids (aa) containing two polypeptide chains, α (21 aa) and β 
(30 aa), with three disulfide bonds. Two of these interlink the α- and β-chains, 
while the additional disulfide bond is an intra α-chain bond important for the 
tertiary structure and the physiological efficacy of the molecule [11]. 
 
 
Figure 2.2.1 – Amino acid sequences of human, bovine and porcine Insulin. 
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The advent of recombinant DNA technology in the early 1980’s provided an 
obvious step towards the growing requirement for Insulin, gradually replacing the 
slaughterhouse supplied animal Insulin for synthesized nucleotide sequences 
coding for the human Insulin. Biosynthesized Insulin was the first recombinant 
product approved by the U.S. Food and Drug Administration (FDA) for human 
application [12, 13]. This first approach developed by scientists at City of Hope 
National Medical Center, USA, in collaboration with Genentech Inc., USA, was 
based on two parallel fermentation and purification processes, one for each Insulin 
chain [14]. The procedure termed “chain combination”, fused the α and β chains to 
carrier proteins, expressed in two different Escherichia coli strains and the purified 
chains were co-incubated under reactions conditions to form intact Insulin. 
Nowadays, there are two economically viable “proinsulin routes” employed. Both 
produce a Insulin precursor (IP) polypeptide from which mature Insulin is derived 
via in vitro proteolytic excision of the “C” or “connecting” peptide. One approach 
continues to apply the bacterial expression system E. coli, producing inclusion 
bodies containing IP, however in a single fermentation protocol, with subsequent 
solubilization and refolding procedures [15]. The other commercially applied route, 
involves the utilization of the yeast Saccharomyces cerevisiae as expression 
system, producing an engineered construct consisting of the Insulin α chain, a 29 
amino acid β chain (lacking the C terminal β-30 threonine, Figure 2.2.1) linked via 
a short synthetic (often AAK) C peptide, and a fused S. cerevisiae α-mating factor 
pre-pro-peptide signal leader sequence [16-18], which facilitates soluble 
extracellular secretion, and is itself enzymatically removed during the process. 
In time, the ability to chemically synthesize genes of altered nucleotide sequence 
was mastered and several Insulin analogues have been engineered to display either 
an accelerated or prolonged duration of action and many have been approved for 
general medical use [12]. Current Insulin-based diabetes research is increasingly 
focused not on the Insulin molecule per se, but upon areas such as the development 
of non-parenteral Insulin delivery systems, as well as organ-/cell-based and gene 
therapy-based approaches to control the disease. In June 2014, the FDA approved 
Afrezza® from MannKind Co., USA, which is an inhaler with pre-measured rapid-
acting Insulin for type 1 and type 2 diabetes. 
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2.3. Pichia pastoris as expression system 
 
Commensurate with the projected escalation in the prevalence of diabetes in the 
coming decades [8], there will be an increased demand for Insulin estimated on 
approximately more than 16000 kg/year [19]. Though S. cerevisiae is still the main 
yeast system for Insulin production, numerous alternative yeast hosts have become 
available in recent years [20-22]. Among these microbial factories, the 
methylotrophic yeast Pichia pastoris has emerged as a very useful expression host 
with superior features [23-25] and has been successfully employed for the high-
level production of Insulin precursor [2].  
Recently, the commonly used recombinant protein production Pichia pastoris 
strains, such as X-33 and GS115, were classified as Komagataella sp. [26]. Since at 
the time this work was performed all the data banks used the Pichia pastoris name 
as well, the earlier denomination (P. pastoris) is used when referring to the strain 
X-33 and GS115.  
 
 
Figure 2.3.1 – Pichia pastoris X33-IP (A) isolated colonies grown in agar plates and (B) In situ 
microscopy image of high cell density culture in 10 L bioreactor. 
 
Pichia pastoris is a single-celled eukaryote which possesses remarkable 
prokaryote-like characteristics. These notable features include the easiness of 
genetic manipulation and rapid growth on relatively inexpensive media similar to 
E. coli [23]. On the other hand, P. pastoris also present unique advantages 
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exclusive to eukaryotes. Among others features, post-translational modifications, 
such as glycosylation and disulfide bridges formation, stand out [24]. As a 
consequence, heterologous proteins are more likely to be correctly processed, 
folded and assembled into functional molecules when produced in P. pastoris 
compared with Escherichia coli [27]. The preference of P. pastoris for respiratory 
growth is a key physiological trait that greatly facilitates its culturing at high-cell 
densities relative to fermentative yeasts (Saccharomyces cerevisiae). Furthermore, 
as a methylotrophic yeast P. pastoris possesses two alcohol oxidase genes, AOX1 
and AOX2, the first has a highly inducible and tightly regulated promoter (PAOX1) 
[28]. The Aox1 promoter is strongly repressed in cells grown on most carbon 
sources; such as glycerol, but it is induced over 1000-fold when cells are shifted to 
a medium containing methanol as a sole carbon source, which is an advantage 
regarding expression control of recombinant proteins which can be toxic to the 
producing cell [23]. In addition, P. pastoris shows a stable integration of 
expression plasmids into the genome and the ability to grow to high cell densities 
(> 100 g L-1 dry cell mass) in bioreactor cultures [29]. Other important 
characteristics that make this expression system an attractive choice are its capacity 
of high level secretion of heterologous protein and the relative low levels of 
endogenous proteins that are secreted to the medium, which facilitates purification 
[30]. Generally in P. pastoris, the entry of heterologous proteins into secretory 
pathway is mediated by the Saccharomyces cerevisiae α-mating factor pre-pro-
peptide signal leader sequence (MFα). The use of this secretion signal peptide can 
lead to recombinant protein concentration in the culture supernatant exceeding 10 
g/L [31].  
 
2.4. Regulation of protein folding and ER stress 
 
The extensive use of Pichia pastoris as a platform for recombinant protein 
expression has been providing the opportunity for deeper understanding of cellular 
physiological responses in diverse extreme environments. It is well established 
today that heterologous overexpression of proteins is connected with different 
stress reactions [32, 33]. In its wider definition, stress is the response of any system 
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to perturbations of its “normal state”. Regarding a living organism these 
disturbances can be either life-enhancing changes, e.g. feeding, or life-threatening 
changes, e.g. starvation. High-level expression of a foreign protein may either 
directly limit other cellular processes by competing for their substrates, or 
indirectly interfere with metabolism, if their manufacture is blocked, thus induce a 
metabolic stress reaction of the cell [32]. The protein folding process and 
subsequent secretion is a rather complex process involving many interacting 
participants. Due to this interdependence, genetically increasing the rate of one step 
can lead to rate-limitation of another one, which can then become the bottleneck of 
the expression system. Moreover, in most cases the rate limiting step in the 
eukaryotic secretion pathway has been identified to be the exit of proteins from the 
Endoplasmic Reticulum (ER) [34].  
It should be noted, however, that most of the knowledge on the Pichia pastoris 
folding machinery is derived from similarity to other yeasts (mainly 
Saccharomyces cerevisiae) and that detailed functional characterization is largely 
missing. 
 
 
Figure 2.4.1 – Schematic representation of protein folding and secretion in ER. Modified 
based on [35]. 
 
The ER is the first compartment in the secretory pathway and is a major protein 
folding compartment in a eukaryotic cell, second only to the cytosol. All secretory 
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proteins enter the secretory pathway through the ER [36]. After synthesis on the 
ribosomes, proteins are translocated through the Sec61 complex translocon pore 
into the ER lumen for modification and delivery to their proper target sites within 
the secretory pathway and the extracellular space. In the ER, proteins fold into their 
native conformation and undergo a multitude of post-translational modifications, 
including signal sequence processing, disulfide bond formation and glycosylation. 
In a process termed quality-control (QC) only correctly folded proteins are 
exported to the Golgi complex, while incompletely folded or misfolded proteins are 
retained in the ER to complete the folding process or in extreme cases to be 
targeted for degradation [37]. Specialized cargo vesicles that selectively 
incorporate these proteins bud from the ER and are targeted to the Golgi membrane 
by the activity of the coat protein complex II (CopII). In the Golgi network proteins 
undergo additional post-translational modifications and are subjected to sorting 
mechanisms that finally target them to their final destination. The accumulation of 
mis/unfolded proteins in the ER lumen results in activation of ER-Nucleus 
signaling pathway called as unfolded protein response (UPR). Upon strong or 
prolonged ER stress, an ubiquitin mediated pathway mechanism called ER-
associated protein degradation (ERAD) is responsible for the retention of 
misfolded or unmodified nonfunctional proteins in the ER and their subsequent 
removal, schematic representation in Figure 2.4.3 [38]. Curiously, in higher 
eukaryotic organisms, when these mechanisms do not remedy the stress situation, 
apoptosis is initiated presumably to eliminate unhealthy or infected cells [39, 40]. 
Several efforts on overcoming protein folding stress for improved recombinant 
protein production had been attempted [41-43]. Promising expectations emerged 
that increased level of secretion helpers, such as PDI, Ero1, Sso2, Kar2 and Hac1, 
would result in increased folding capacity in the ER, and thus improved secretion 
rates, however the findings were rather inconsistent and unpredictable. It seems 
that the effect of co-expression strongly depends on the properties of the target 
protein and, moreover, it seems that fine-tuned overexpression of these genes are 
required to generate a functional secretory network to improve foreign protein 
overproduction, recently reviewed in [44]. 
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2.4.1. The ER-resident protein folding machinery 
 
The endoplasmic reticulum (ER) harbors a protein folding machinery that folds 
client proteins, quality controls the folding process, and, when necessary, activates 
the unfolded protein response [36]. The folding demand arises from nascent 
polypeptide chains entering the ER in a mis/unfolded conformation. Misfolded 
proteins containing cytoplasmic, intramembrane or endoplasmic reticulum (ER)-
luminal lesions are recognized by cytoplasmic and luminal chaperones and 
associated factors (listed in [36]) which can facilitate protein translocation, protein 
folding, and, when necessary, protein degradation. The ER-resident protein folding 
machinery consists of: foldases (e.g., thiol oxidoreductases), molecular chaperones 
(e.g., Hsp70, Hsp40), the ER lectins (e.g., calnexin, calreticulin), and the AAA 
ATPase proteins.  
Foldases can present thiol oxidase, disulfide isomerase, and chaperone activities. 
The most prominent example of protein foldase families are protein disulfide 
isomerases (PDIs) and cis–trans peptidyl prolyl isomerases (PPIs). These proteins 
catalyze the formation and isomerization of disulfide bonds and the cis–trans 
isomerization of peptidyl prolyl bonds, respectively. To catalyze disulfide bond 
formation and present thiol oxidoreductase activity, PDI must be maintained in an 
oxidized state which is accomplished by oxidoreductin 1 (Ero1), an ER membrane 
protein [45, 46]. In the oxidative environment provided by the ER, Ero1 passes 
electrons to molecular oxygen via FAD, potentially creating reactive oxygen 
species (ROS).  
Molecular chaperones are found in endoplasmic reticulum (ER), cytosol and 
mitochondria and play a vital role in protein biogenesis, translocation and 
degradation [47]. They interact with hydrophobic surfaces on unfolded proteins, 
thereby shielding them from engaging in non-productive interactions with other 
polypeptide chains [48]. They do not enhance the rate of protein folding. The major 
classes of chaperones include, the helper proteins Hsp70, the Hsp40 (co-
chaperones), the nucleotide exchange factors (NEF), the Hsp90 and the Hsp110. 
The most important chaperones are those that belong to the Hsp70 family, having a 
molecular weight of about 70 kDa and are upregulated due to changes in 
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temperature, oxidative stress, among others. Whereas in Escherichia coli Hsp70 is 
termed DnaK, in eukaryotes as in yeast cells, which expresses several slightly 
different Hsp70 proteins, the chaperones located in the ER are called BiP/Grp78, 
and in yeast, Kar2 [49]. Chaperone activity of Hsp70 is ATP dependent and 
includes cycles of ATP hydrolysis and protein binding [50]. Hsp70s play a vital 
role in protein folding, translocation, disassembly of aggregates and targeting 
proteins to the ER-associated protein degradation pathway. Hsp40s, in E. coli DnaJ, 
act as co-chaperone and enhance the ATPase activity of Hsp70 [51]. NEFs help in 
release of ADP from ATPase binding domain, a rate limiting step in the Hsp70 
cycle [52]. Hsp110s are distantly related to Hsp70s and can act as NEF stimulating 
ATPase activity and also act as holdase preventing protein aggregation [52].  
N-glycosylation has a major initial role in signaling of protein folding steps 
involving many proteins that enter the ER. The recognition of monoglucosylated 
species is performed by the ER lectin chaperones calnexin, and its homologue 
calreticulin [37]. After removal of two terminal glucose residues, calnexin binds to 
specific oligosaccharides, exhibiting its chaperone function. Removal of the last 
glucose residue releases calnexin from the glycoprotein, thus enabling further 
folding or targeting towards degradation. While S. cerevisiae lacks the gene for 
UGGT (the mammalian enzyme re-adding glucose to the glycan and thus recycling 
proteins to calnexin binding [53]), a homolog was identified in P. pastoris [54]. In 
Saccharomyces cerevisiae nascent glycoproteins are bound by Cne1, a homologue 
of the mammalian calnexin [55].  
 
2.4.1.1. Immunoglobulin heavy chain binding protein – Kar2 
 
The accumulation of unfolded proteins in the ER lumen triggers the transcription of 
a large set of stress responsive genes encoding ER resident chaperones and 
foldases, including the main UPR marker, Kar2 [38, 56]. The most prominent ER 
molecular chaperone Kar2, in yeast, (also known as BiP/Grp78/HspA5 in other 
organisms) belongs to Hsp70 family of heat shock proteins and it is present in the 
lumen of the ER of all eukaryotes. In addition to relieve stress by chaperoning 
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protein folding, relying on a number of interaction partners, including Hsp40 co-
chaperones, nucleotide exchange factors, and signal transducers, Kar2 also acts as: 
sensor protein for the presence of un-/misfolded proteins, import and export of 
protein in the ER, protein degradation and calcium homeostasis [57]. Kar2 also 
takes part in protein quality control, upon persistent misfolding, N-glycosylated 
polypeptides are slowly released from calnexin/Cne1 and enter a second level of 
retention-based ER quality control by aggregating with the Kar2 chaperone 
complex [53]. The first identified Kar2 homolog was in fibroblasts, whose rate of 
synthesis is increased when cells are starved of glucose, hence its name glucose-
regulated protein, Grp78 [58]. The origin of the other Kar2 homolog BiP comes 
from its identification as a cofactor of immunoglobulin assembly, hence the name 
immunoglobulin heavy chain binding protein BiP [59]. Kar2 has ~74 kDa and is 
the product of a karyogamy gene, KAR2 [49], hence the terminology, whereas in 
Escherichia coli it is homolog to the bacterial DnaK. Kar2 has an N-terminal 
ATPase and a C-terminal substrate binding domain. When bound to substrates the 
ATPase activity of Kar2 is stimulated, cycling ADP–ATP by folding polypeptide 
chains, consuming energy (Figure 2.4.2) [48]. These reactions are regulated by co-
chaperones, also called J-proteins in reference to the E. coli enzymes [51], and can 
be inhibited by depleting cellular ATP [60, 61]. ER-resident family members such 
as Kar2 have a C-terminal tetrapeptide ER retention signal, usually KDEL in 
animal cells and HDEL in yeast [62]. The HDEL motif is recognized by Erd2, a 
membrane protein in yeast, which is responsible for indicating the retention of 
these ER-resident proteins in the ER lumen [63, 64], or the motif is recognized by 
the respective receptor in the Golgi apparatus, leading to packaging of the ER-
protein into CopI vesicles and retrograde transportation to the ER [65-67].  
Over the last decade Kar2 protein has attracted even more attention due to the 
involvement of UPR in progression of critical human diseases, such as metabolic 
disease, neurodegenerative disease, inflammatory disease, and cancer [68]. In 
cancer, due to environmental changes such as poor vascularization and the 
resulting hypoxia and glucose starvation, tumor cells are prone to ER stress and 
UPR. Endoplasmic reticulum storage diseases are listed in [36] and were recently 
reviewed in [69]. 
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Figure 2.4.2 – The folding cycle of Kar2, a chaperone belonging to the Hsp70 family. Figure 
modified based on [47]. 
 
 
2.4.2. The unfolded protein response (UPR) 
 
To maintain ER homeostasis the quality control systems ensure that only correctly 
folded, modified and assembled proteins travel further along the secretory pathway 
of the Golgi apparatus. Overproduction of recombinant proteins and other 
disturbances may overload the ER folding and secretion capacity, resulting in the 
accumulation of misfolded or unfolded proteins, and ER stress as a consequence. 
This triggers the activation of the unfolded protein response (UPR) pathway, which 
aims at reducing ER stress conditions by induction of genes involved in protein 
folding and the ER-associated degradation (ERAD) pathway [36, 47, 56]. The 
initial description and major progress in understanding the molecular mechanisms 
of the UPR was done using the yeast S. cerevisiae [70, 71]. Specifically, this yeast 
was used for the molecular cloning of the UPR transducer Ire1 and the UPR-
specific transcription factor Hac1 [72].  
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Figure 2.4.3 – Diagram representing the protein folding, secretion, UPR and ERAD in yeast. 
Modified based in [73]. 
 
In yeast UPR, represented in Figure 2.4.3, misfolded proteins in the ER are sensed 
by the Ire1-bound Kar2. Ire1 is a transmembrane protein oriented with the N-
terminal in the ER lumen and the C-terminal in the cytosol [74]. Ire1, when 
activated promotes the splicing of the message for the Hac1 transcription factor. 
Hac1 activity is regulated by an unconventional splicing event of HAC1 messenger 
RNA (mRNA), removing an intron that prevents its translation in the absence of 
ER stress. If unfolded proteins accumulate in the ER, Kar2 dissociates from 
monomeric Ire1 to perform its chaperone function, and Ire1 dimerizes and gets 
activated. After removing the intron from precursor HAC1u mRNA (HAC1 
splicing), the exons are joined by tRNA ligase Rgl1 to form translation-competent 
HAC1i mRNA. The encoded Hac1 protein then locates to the nucleus and activates 
target genes with UPR elements (UPREs) in their promoters [71, 72]. Hac1 is 
known to activate or repress over 100 genes, including KAR2, PDI and ERO1 in S. 
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cerevisiae [75]. The induced transcriptional response aims at restoring ER 
homeostasis by increasing the ER lumen and surface area as well as the ER folding 
machinery.  
The HAC1 gene and splice event was recently characterized in Pichia pastoris [76]. 
P. pastoris HAC1 contains a 322 bp intron, flanked by splicing sites, similar to 
homologs from other species. As in S. cerevisiae, HAC1 splicing is dependent on 
Ire1 in P. pastoris, and the last five amino acids of the newly generated C-terminus 
of P. pastoris Hac1 are required for UPR activation [77]. HAC1 mRNA is 
constitutively expressed in P. pastoris independent of externally applied ER stress 
conditions or recombinant protein production [76], but because of the secondary 
structure of the intron, no protein is produced when the mRNA remains unspliced 
[78]. Regarding this matter, the occurrence of UPR activity in “unstressed” cells 
was implicated in nutrient sensing and control of cellular responses to fluctuations 
in nutrient levels, extending the physiological functions of the UPR [79-82]. 
Furthermore, recent studies on a P. pastoris strain secreting human serum albumin 
at µ = 0.015 to 0.15 h–1 in glucose-limited chemostat cultivations illustrated that the 
yeast reacts to different growth rates by tuning genes involved not only in carbon 
and nitrogen sources but also those regulating stress responses, e.g. the UPR [83].  
 
2.5. Environmental stresses 
 
The impact of environmental factors on P. pastoris cells has been investigated in 
the past years and the changes in the proteins involved in folding and degradation 
were always object to better understand their effect on the final recombinant 
product yield [32, 33]. In order to achieve heterologous protein overexpression 
cells usually undergo typical high cell density fermentation processes which exert 
growth conditions that deviate far from their natural environment. Temperature, 
pH, solute concentration, oxygenation, metal ion concentration, or high levels of 
organic compounds are typical environmental stress factors. Overlapping global 
expression programs in response to a diverse set of stresses, including their specific 
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features and a common response to all of the stressful conditions, are generally 
termed “environmental stress response” (ESR) pathway.  
A study on the responses of Saccharomyces cerevisiae to a variety of 
environmental stresses concluded that a common program for genome wide 
transcriptional changes exists as a reaction to diverse environmental changes, 
encompassing roughly 900 genes [84]. Generally, it was observed that the ESR 
genes are up- or downregulated transiently as a reaction to a shift to stressful 
conditions, and return to the near normal level after adaptation to the new 
conditions. Studies with Pichia pastoris in which the cultivation temperature was 
decreased from 30 to 20 °C led to a 3 fold increase in specific productivity of 
recombinant protein in spite of downregulation of chaperones from the Hsp70 
family, such as Ssa4 and Ssb1, as well Hsp60 and Hsp82; Kar2 was also 
downregulated while the PDI did not show any change at lower temperatures [85]. 
Regarding environmental oxygen availability, very little is known about its impact 
on the physiology of recombinant Pichia pastoris in comparison to other yeasts. 
Recent studies on P. pastoris report that under steady state conditions, low oxygen 
availability strongly affected among others, the stress responses, particularly the 
unfolded protein response [86, 87]. Additionally, a beneficial effect of hypoxia on 
recombinant protein secretion in P. pastoris chemostat cultivations has been 
reported [88].  
In biotechnological processes, hyperosmotic stress is regarded as a typical problem, 
as in high cell density bioreactor cultivations, media initially contain high 
concentrations of major nutrients (e.g., carbon sources such as glucose or glycerol) 
and salts. Osmotically active compounds may either be ionic (dissociated salts or 
organic acids) or uncharged (e.g., sugars, sugar alcohols, or undissociated organic 
acids). Depending on the severity of the osmotic change to which S. cerevisiae is 
submitted, it presentes usually the induction of the environmental stress response 
(ESR) and of the high osmolarity glycerol (HOG) pathway [84, 89, 90]. These 
metabolic fine-tuning allow the yeast cells to cope with external ionic 
hyperosmolarity by producing compatible solutes, generally glycerol, 
osmoregulating internal cellular environment, inducing, among a multitude of 
cellular readjustments, the transcription of glycerol-3-phosphate dehydrogenase 
(GPD1) and repression of the plasma membrane glycerol efflux channel (FPS1) 
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[91-94]. While so far there is no evidence that UPR triggers an osmoresponse such 
as production of compatible solutes or confers resistance to salt, adaptation to 
hyperosmotic conditions has been shown to activate an UPR-like response 
including upregulation of chaperones (e.g., Kar2) in Pichia pastoris, whereas in 
strains already having UPR activation due to recombinant protein overproduction, 
the effect of elevated osmolarity is less pronounced [95].  
Environmental nutrient sensing and control of cellular responses to fluctuations in 
nutrient levels have been suggested to be a second physiological function for the 
UPR in yeast and mammals [36, 96]. Observations uncover that in addition to 
keeping the biosynthetic burden and biosynthetic capacity of the ER in line, the 
UPR also monitors the biosynthetic activity of the ER to inform the cell about its 
overall metabolic state. In diploid budding yeast, high nitrogen concentrations in 
the medium are responsible for an increased influx of nascent unfolded polypeptide 
chains into the ER and activation of Ire1, regulating HAC1 mRNA splicing [79]. 
 
2.6. Oxidative stress 
 
Oxidative stress can be simply defined as a state where there is a relative imbalance 
within cells between generation and removal of reactive oxygen species (ROS). It 
has been shown that some classical markers of the UPR pathway have an important 
role in attenuating oxidative stress in yeast and in mammals [75, 82]. ROS 
adversely affect cell viability and possibly the quality of the protein product, trigger 
apoptosis, and function as signaling molecules in the UPR [97]. Regarding 
methylotrophic yeasts, oxidative stress caused by methanol degradation is a 
relevant issue. Methanol is first oxidized inside the peroxisomes by alcohol oxidase 
(Aox1) to form formaldehyde (CH2O) and hydrogen peroxide (H2O2), which are 
both highly toxic compounds that increase the intracellular ROS levels (Figure 
2.6.1) [98]. Formaldehyde is a central intermediate situated at the branch point 
between assimilation and dissimilation pathways [99], and is promptly 
metabolized. On the other hand, H2O2 despite having no unpaired electrons and 
thus is not a radical, it is often qualified as ROS since it can easily convert itself 
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into the highly reactive hydroxyl radical (•OH), thus generating oxidative stress. 
Another central source of reactive oxygen species with consequent UPR activation 
is the oxidative protein folding [97, 100, 101]. PDI and other foldases are 
responsible for the correct formation of disulfide bonds during oxidative folding 
and the isomerisation of incorrectly folded disulfides [46, 47]. Therefore, the rate 
of ROS generation is dependent upon the complexity of the protein to be folded, 
heterologous or not, the availability of chaperones to assist folding and ATP used 
by chaperones [97, 101]. As already mentioned, in the oxidative environment 
provided by the ER, Ero1 passes electrons to molecular oxygen via FAD, 
potentially creating ROS [45, 46]. The yeast ER has one Ero1 and mammals have 
two isozymes, Ero1α and Ero1β. Ero1α is induced by hypoxia and may play a role 
in ERAD [102, 103], whereas Ero1β is induced by the unfolded protein response 
[104]. The relevance of this oxidative-stress-generating process can be illustrated 
by the estimation that the Ero1-mediated oxidation could account for up to 25% of 
cellular ROS produced during protein synthesis [97].  
 
 
Figure 2.6.1 –Oxidative protein folding in the yeast ER diagram. Modified from [97]. 
FAD-bound Ero1 oxidizes PDI, which then subsequently oxidizes folding proteins directly, 
thereafter passing electrons to molecular oxygen, presumably resulting in the production of ROS. 
FAD, which is synthesized in the cytosol, can readily enter the ER lumen and stimulate the activity 
of Ero1. Disulfide isomerization and reduction may be performed by PDI. Reduced glutathione 
(GSH) may also assist in disulfide reduction mediated by Pmp20, resulting in the production of 
oxidized glutathione (GSSG). 
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3. Aim of this work 
 
The main goal of the work presented here was to perform a comprehensive analysis 
of the unfolded protein response (UPR) pre and post methanol induction of the 
yeast Pichia pastoris producing and non-producing an Insulin precursor (IP) in 
bioreactor cultures under control of the tightly methanol-regulated promoter 
(PAOX1). The cellular folding response during pre-induction glycerol batch phase, 
the transition to methanol induction medium and the post-induction methanol fed-
batch phase were studied in detail. Additionally, the IP producing yeast’s unfolded 
protein response under industrially-relevant bioreactor fed-batch conditions were 
investigated, allowing a wide comparison of the UPR related results.  
A further stress response - the oxidative stress - was analyzed through flow 
cytometry by monitoring reactive oxygen species (ROS). The effect of methanol 
metabolism and recombinant protein production on ROS levels was studied. 
Finally, the role of methanol induction at different phases of glycerol batch growth 
of IP producing cells on ROS levels was monitored. 
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4. Methods 
4.1. Water and sterile work 
 
For all experiments ultrapure water, purified with Arium Pro VF (Sartorius, 
Germany), was used. Aseptic operations, which required sterility to avoid 
contaminations, were performed under a clean bench (Herasafe KS, Thermo 
Scientific, Germany). All solutions for the cultivations were sterilized by filtration 
(0.2 µm filter) or autoclaving at 121 °C for 20 min (Systec V-150, Systec GmbH, 
Germany). 
 
4.2. Strain and vector 
 
The X-33 Insulin producer Pichia pastoris strain Mut+ phenotype used for the 
experiments in this work is described previously [2]. The constructed expression 
vector pPICZα-IP contains a synthetic codon-optimized gene encoding the IP under 
the control of the PAOX1 promoter, in-frame with the α-factor secretory signal 
sequence of Saccharomyces cerevisiae. The P. pastoris GS115 strain carrying 8-
copies of the HBsAg gene under the control of the AOX1 promoter has been 
described before [105]. 
 
4.3. Optical density and determination of cell 
concentration 
 
The cell concentration (biomass) of suitably diluted culture samples was measured 
by optical density (OD600) at 600 nm using a Multiskan GO UV-
Vis spectrophotometer (Thermo Fisher Scientific, Germany), previously zero-
calibrated with 1x PBS [8 % (w/v) sodium chloride, 0.2 % (w/v) potassium 
chloride, 1.42 % (w/v) disodium hydrogen phosphate and 0.245 % (w/v) potassium 
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phosphate]. The measurements were performed with disposable plastic cuvettes 
with a path length of 1 cm. For dry cell mass (DCM) determination, 1 mL aliquots 
of the culture broth were pelleted (13,000 rpm for 15 min at room temperature 
using an Eppendorf microcentrifuge, Germany) in pre-weighed tubes, re-suspended 
in 50 mmol/L phosphate buffer (pH 7.2), re-centrifuged and the resultant pellets 
dried at 80 °C to constant mass.  
 
4.4. Pichia pastoris cultures 
 
Three different protocols were employed to cultivate the yeast cells. Cells were 
submitted either to an entire glycerol batch and methanol induction phase in the 
shake flasks protocol, or both phases exclusively in bioreactor, or employed in a 
bioreactor glycerol batch and methanol shake flask fed-batch mixed alternative 
scheme.  
 
4.4.1. Shake flask cultivations 
 
A starter culture was set up by inoculating 100 mL containing yeast extract (1 % 
w/v), peptone (2 % w/v) and dextrose (2 % v/v) in 500 mL sterile baffled shake 
flasks with initial OD600 of 0.03 from glycerol stock cultures and grown at 30 °C, 
under constant shaking in an orbital shaker at 160 rpm for 18 h to an OD600 10. 
About 1 % of starter culture was used to inoculate 500 ml of buffered glycerol 
complex medium (BMGY) containing 1 % (w/v) yeast extract, 2 % (w/v) peptone, 
100 mmol/L potassium phosphate (pH 6.0), 1.34 g/L yeast nitrogen base with 
ammonium sulfate and without amino acids, 0.4 mg/L biotin and 5 % (v/v) glycerol 
in a 2 L baffled shake flask. The culture was incubated at 30 °C, under constant 
shaking in an orbital shaker at 150 rpm until an OD600 ~20 was reached. 
Subsequently, cells were pelleted by centrifugation (3347 × g), washed with sterile 
1x PBS, re-centrifuged and re-suspended in buffered methanol complex medium 
(BMMY), as above described but containing methanol 1 % (v/v) instead of 
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glycerol, to an OD600 ~100 and incubated at 30 °C under shaking at 150 rpm. 
Recombinant protein production was induced through the addition of 1 % (v/v) 
methanol twice a day at 12 h intervals for a total period of 96 h. Finally, cells were 
harvested by centrifugation, washed with 1x PBS, and the cells were stored at -
80°C until use. 
 
4.4.2. Bioreactor cultivations 
 
To achieve more reproducibility between batch-to-batch experimental results, a 
single colony upscaling approach was employed for bioreactor cultures and the 
undesired production of the byproduct ethanol was avoided. Instead of directly 
transferring frozen cells into pre-cultures medium, as employed for the shake flask 
cultures, cryo bank pellets were diluted, cells were cultured in agar plates, colonies 
were isolated, only then transferred to complex media pre-cultures, thereafter to the 
inoculum containing the 25 g/L glycerol defined medium and finally into the 
bioreactor. X33 and X33-IP cryo cell banks were diluted and cultured in 2 % (w/v) 
agar plates containing: yeast extract (1 % w/v), peptone (2 % w/v) and dextrose (2 
% v/v) medium in order to grow isolated single colonies. One single colony of 
either strain was transferred to a 100 mL sterile baffled shake flask containing 25 
mL of medium with 1.34 g/L sterile yeast nitrogen base with ammonium sulfate 
and without amino acids, 5 g/L sterile glycerol and 0.4 mg/L biotin. This starter 
culture was grown in an orbital shaker at 30 °C and 160 rpm until an OD600 ~5 was 
reached. Thereafter, the pre-inoculum culture was prepared with 1 % (v/v) of the 
starter culture in one 500 mL sterile baffled shake flask filled with 100 mL of the 
same complex medium described above and cultured until OD600 ~5. Subsequently, 
the pre-inoculum was used to inoculate the inoculum, at an initial OD600 of 0.5, two 
2 L sterile baffled shake flasks filled with 500 mL of defined growth media 
containing per liter: glycerol, 25 g; potassium dihydrogen phosphate, 9.4 g; yeast 
trace metal (YTM) solution, 4.56 g; ammonium sulfate, 15.7 g; magnesium sulfate 
heptahydrate, 4.6 g; calcium chloride dihydrate, 0.28 g; and biotin, 0.4 mg. The 
YTM solution contained per liter: potassium iodide, 207.5 mg; manganese sulfate, 
760.6 mg; disodium molybdate, 484 mg; boric acid, 46.3 mg; zinc sulfate 
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heptahydrate, 5.032 g; ferric chloride hexahydrate, 12.0 g; and sulfuric acid, 9.2 g. 
The inoculum cultures contained, when mentioned, the previously described 
complex media. All shake flask cultures were grown at 30 °C and 160 rpm with 
starting OD600 of 0.1. The cellular growth was monitored by optical density 
measurements at 600 nm in a Multiskan GO UV-Vis spectrophotometer (Thermo 
Fisher Scientific, Germany). For details on the composition of the inoculum culture 
media refer to Appendix I item 10.1. 
The controlled batch cultivations were performed in 2 L Biostat® B plus or 10 L 
Biostat® C systems and the feed-back controlled fed-batch cultures in 5 L Biostat® 
B (Sartorius, Germany). Bioreactor cultivations were started with an initial OD600 
of 0.5. The application of the two-phase fed-batch process for Insulin precursor 
production is described in detail in Appendix I item 9.2. During the cultivation, the 
temperature and pH were kept constant at 30 °C and pH 5.5. For maintaining the 
pH, 12.5 % (v/v) ammonium hydroxide and 1 mol/L phosphoric acid were used. In 
case of foaming, 1 mL antifoam Ucolub N115 per 1 L culture media was manually 
supplemented into the bioreactor. The aeration rate was set to 1,75 vvm and the 
stirrer speed was regulated between 400 and 2000 rpm gaining constant dissolved 
oxygen (DO) concentration of 20 % air saturation. The concentrations of oxygen 
and carbon dioxide in the exhaust gas were determined by BlueInOne gas sensors 
(BlueSens, Germany). The same above described defined media was employed 
with either glycerol or glucose as carbon source. Complete consumption of 
glycerol or glucose in the medium was recognized by a massive decline in stirrer 
speed, which correlates to reduced oxygen uptake of the cells due to nutrient 
depletion. Production of recombinant Insulin precursor was initiated by addition of 
a methanol solution [96 % (w/w) methanol and 4 % (w/w) YTM] to the mentioned 
final methanol concentration, which was maintained constant throughout the 
remainder of the induction period based on on-line measured methanol 
concentrations determined from the methanol vapor in the off-gas using a flame 
ionization detector (Ratfish Instruments, Germany). Based on the gas liquid phase 
equilibrium methanol concentrations were determined in the off-gas using two 
point calibrations directly before and after induction (detailed FID calibration 
values and operation are described on Appendix I item 9.2).  
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4.4.3. Bioreactor batch and shake flask fed-batch protocol 
 
The alternative shake flask fed-batch protocol was employed with cells were 
harvested sterile from the 10 L defined medium glycerol batch during different 
growth phases, centrifuged, washed with 1x PBS and re-suspended to an final 
OD600 ~100 in buffered methanol complex media containing 1 % (w/v) yeast 
extract, 2 % (w/v) peptone, 100 mmol/L potassium phosphate (pH 6.0), 1.34 g/L 
yeast nitrogen base with ammonium sulfate and without amino acids, 0.4 mg/L 
biotin and 1 % (v/v) methanol. Cultures were grown in 150 mL sterile baffled 
shake flasks with 25 % filling volume in an orbital shaker at 30 °C and 160 rpm. 
Recombinant protein production was induced through the addition of 1 % (v/v) 
methanol twice a day at 12 h intervals for a total period of 96 h.  
 
4.5. Calculations 
 
The estimation procedure to calculate the specific growth rate (µmax) was 
performed by using suitable smoothing routines and mass balances that permitted 
to supply complete data sets with coincident off-line biomass and substrate values. 
Carbon dioxide production rate (CPR), oxygen uptake rate (OUR) and the 
respiratory quotient (RQ) were calculated as described elsewhere [106]. 
 
4.6. Analytical methods 
 
Ethanol concentrations were determined by gas chromatography (Shimadzu 14B 
GC, Kyoto, Japan) using a Supelcowax 10 column (Sigma-Aldrich, Germany), 
injector temperature 180 °C, column temperature 70 - 160 °C, detector temperature 
280 °C, n-Propanol (8 g/L) internal standard, injection volume of 0.2 µL and a 
flame ionization detector. The osmolarity of the culture supernatant samples was 
measured by freezing-point depression with an Osmomat 3000 (Gonotec, 
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Germany). The glucose concentration of supernatants samples was measured by 
YSI 2950 Biochemistry Analyzer (YSI Life Sciences, UK). Supernatants glycerol 
concentration was determined by high performance liquid chromatography 
Chromaster system (Hitachi, USA) with an Aminex HPX-87H column (Bio-Rad 
Laboratories, USA) at 60 ºC using 0.005 mol/L H2SO4 as the mobile phase at a 
flow rate of 0.6 mL/min and monitored by a refractor index detector.  
 
4.6.1. Determination of purified IP concentration 
 
The purified IP protein contents were measured by PierceTM bicinchoninic acid 
(BCA) protein assay kit with bovine serum albumin (BSA) as standard. The total 
protein was quantified identically as described in protocol provided with kit [107]. 
For all standard curves a minimal linear regressive coefficient of 0.99 was 
considered. In addition, protein concentrations were reconfirmed by dry-weight 
protocol. Determined volumes of purified IP solution dialyzed against 1x PBS 
buffer and solely 1x PBS buffer solution were separately lyophilized in pre-
weighed and clean weighing conical centrifuge tubes. After freeze-drying was 
completed, the resulting powders were weighed and protein concentration was 
determined by discounting the mass difference per unit of volume between the 
IP/1x PBS solution and the 1x PBS solution.  
 
4.6.2. SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Culture broth was harvested, centrifuged at 13,000 rpm for 5 min; cell pellets and 
supernatants were separated and stored at -80 °C until use. The intracellular and 
extracellular fractions were analyzed by SDS-PAGE 12 or 16 % and Western blot. 
The formulation of stacking and separation gels mixture for 12 and 16 % SDS-
PAGE is given in Table 4.6.1. Cell pellets were washed with ice-cold 1x PBS, re-
suspended in cell lysis buffer (25 mmol/L potassium phosphate buffer pH 8.0, 5 
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mmol/L EDTA, 8 % (w/v) glycerol, 500 mmol/L sodium chloride), and normalized 
to a final OD600 of 50. After 1:1 dilution with loading buffer (20 mmol/L Tris-HCl 
pH 8.0, 2 mmol/L EDTA, 5 % (w/v) SDS, 0.02 % (w/v) bromophenol blue, 5.5 % 
(v/v) glycerol, 20 % (v/v) 2-Mercaptoethanol), samples were boiled for 1 h at 96 
°C and aliquots were loaded into the 12 or 16 % SDS-PAGE gel. The extracellular 
samples were 1:1 diluted with modified loading buffer (as described before 
however with 10 % (v/v) 2-Mercaptoethanol) and boiled at 96 °C for 5 min and 
loaded into the SDS-PAGE gels. The gel lanes were loaded with 7 µL sample 
(intra-/extracellular) and run at 60 V during the stacking and 110 V during the 
separation. The separated proteins were either stained with Coomasssie brilliant 
blue solution (8.5 % (v/v) phosphoric acid, 10 % (w/v) ammonium sulfate, 0.1 % 
(w/v) Coomassie Blue G-250 and 20 % (v/v) methanol) or electrobloted onto a 
PVDF membrane (Bio-Rad Laboratories, USA).  
 
Table 4.6.1 – Composition of resolving and stacking SDS-PAGE gels 
 
Resolving gel 12 % 
(mL) 
Resolving gel 16 % 
(mL) 
Stacking gel 6 % 
(mL) 
NF-Acrylamide/Bis-solution 40 % 
(29:1) 
3.00 3.75 0.75 
Resolving buffer 1.5 mol/L Tris 
HCl pH 8.8 
3.20 3.20 - 
Stacking buffer 1.5 mol/L Tris 
HCl pH 6.8 
- - 0.63 
1 % (w/v) SDS 1.00 1.00 0.30 
Ultrapure water 2.80 2.05 3.77 
25 % (w/v) APS 0.02 0.02 0.01 
TEMED 0.02 0.02 0.01 
 
4.6.3. Western blotting 
 
Proteins separated on SDS-PAGE were electrotransferred using Bio-Rad Semi-dry 
Western blot apparatus onto polyvinylidene difluoride (PVDF) membrane. Prior to 
transfer PVDF membrane was soaked in methanol for a short time and then soaked 
in transfer buffer (25 mmol/L Tris, 200 mmol/L glycine and 20 % (v/v) methanol) 
along with thick filter pads for 5 min. The transfer was carried out at constant 
voltage of 15 V for 45 min at room temperature. After transfer, the membrane was 
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removed and incubated in blocking solution (5 % (w/v) skim milk, 2 % (w/v) 
polyvinylpyrrolidone, 1 % (v/v) Tween 20 in 1x PBS pH 7.2) for 2 h on a shaker at 
room temperature. Subsequently, the membrane was washed thrice with PBS-T (1x 
PBS containing 1 % (v/v) Tween 20) and incubated for 1h on a shaker at room 
temperature with mouse monoclonal primary antibody anti-HDEL (2E7) (sc-
53472; Santa Cruz Biotechnology, USA), diluted to 1:1000 in PBS-T containing 
5% skimmed milk and 2 % (w/v) polyvinylpyrrolidone. After incubation blots were 
washed thrice with PBS-T and incubated for 1h in a shaker at room temperature 
with secondary antibody (goat anti-mouse IgG H and L chain specific peroxidase 
conjugate (Calbiochem, USA), diluted 1:5000). Thereafter blots were again washed 
thrice with PBS-T and developed with TMB (3,3´,5,5´tetramethylbenzidine, 
Sigma-Aldrich, Germany) substrate until the bands were clearly visualized. All 
steps in immunoblotting were carried out on an orbital shaker. Each wash step was 
carried out for 5 minutes. 
 
4.6.4. Kar2 normalized quantification 
 
A normalized abundance analysis of Kar2 was performed during the entire thesis, 
allowing a representative comparison between different experimental conditions. 
Kar2 abundance changes were measured by densitometry analysis of Western blot 
membranes and SDS-PAGE gel images with ImageJ software (National Institutes 
of Health, USA). To enable representative analysis between conditions, the 
compared intracellular lysate or extracellular samples were prepared, loaded and 
run in two 12 % SDS-PAGE gels. One gel was stained with Coomassie for later 
analysis and the separated proteins in the other gel were electrotransferred onto 
Western blot PVDF membranes with subsequent anti-HDEL antibody incubation. 
The 12 % SDS-PAGE gels were either loaded with intracellular lysate samples 
previously normalized by optical density corresponding to an OD600 of 50 and/or 
directly with extracellular supernatant fractions. Densitometry analysis allowed the 
determination of the Kar2 band area in the Western blot PVDF membrane image 
and the determination of the total intracellular/extracellular protein lane area from 
the corresponding time point sample in the Coomassie stained SDS-PAGE 12 % 
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gel image. The division of both estimated area values resulted in a normalized 
quantification of detectable Western blot Kar2 levels in the SDS-PAGE 
intracellular and/or extracellular Pichia pastoris fractions, termed Kar2 Western 
blot relative abundance. 
 
4.6.5. Identification of protein bands by MALDI TOF 
 
The SDS-PAGE band containing proteins were excised from the gels, washed 
thrice with Milli-Q water and additional two wash steps alternatively with Milli-Q 
water and acetonitrile by keeping in thermomixer for 5 mins at 300 rpm 
(Eppendorf, Germany). Thereafter a drying step in a speed vacuum centrifuge 
(Eppendorf, Germany) for 1 hour at 30 °C was performed, followed by freezing the 
samples at -80 °C. The spots were processed as follows. Identification of proteins 
bands were performed as described elsewhere [4]. Briefly, peptide mass 
fingerprints obtained by the MALDI TOF MS were processed using FlexAnalysis 
2.0 (Bruker Daltonics GmbH, Germany) and used to search the NCBInr database 
by using Mascot 2-.10 software (http://www.matrixscience.com). The parameters 
used for searching were as follows: taxonomy: other Fungi, tryptic digestion, 
modifications were allowed for carbamidomethylation of cysteine (fixed 
modification) and methionine oxidation. Proteins with MASCOT score (probability 
based MOWSE scores) greater than 78 were considered significant (P < 0.05) as 
described elsewhere [4, 73]. 
 
4.7. Purification of Insulin precursor 
 
Culture broth was first centrifuged, filtrated with 0,22 µm filters and frozen at -80° 
C. The supernatant was diluted 1:4 with sterile ultrapure water with 1% Tween 20 
(pH 2.0, 4.7 mS/cm) to reduce the salt content (conductivity of culture broth was 
24.2 mS/cm), the pH and the viscosity for more efficient binding to the Streamline 
SPXL resin (GE Healthcare, USA). The ultrapure H2O with 1 % Tween 20 and 
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supernatant solution were mixed with 32.5 mL sediment bed of StreamLine SPXL 
resin and left overnight for interaction under agitation and 4 °C. After loading, the 
column was packed and washed with ultrapure water (pH 5.8) until the absorbance 
at 280 nm returned to base line in elute. Following, the bound IP was eluted using 
conventional chromatography using 1 mol/L sodium chloride (pH 7.5, conductivity 
~100 mS/cm). Protein containing fractions (absorbance at 280 nm) were pooled. 
The pool was dialyzed against 1x PBS in Centricon falcon with MWCO of 3000 
kDa. Lyophilisation was performed for storage and future quantification analysis.  
 
4.8.  Quantification of Insulin precursor by RP-HPLC 
 
Filtered aliquots of Pichia pastoris cell-free supernatants and purified Insulin 
precursor powder, in several concentrations, were mixed 1:1 with solution A [0.15 
% (v/v) TFA in ultrapure water] and analyzed by reversed-phase high performance 
liquid chromatography (RP-HPLC) using a 3 µm SUPELCOSIL™ LC-304 column 
(3.3 cm × 4.6 mm) with a Chromaster liquid chromatography system (Hitachi, 
USA), equipped with an autoinjector (model 5210), UV-VIS detector (model 
5420), pumps A and B (model 5110), and a column oven whose temperature was 
maintained at 24 °C (HPLC column oven, model 5310). Elution was performed 
with a gradient formed by mixing solutions A and B [0.15 % (v/v) TFA in 
acetonitrile] as follows: 10 % B (0 - 6 min), 10 – 43 % B (6 - 41 min), 43 – 100 % 
B (41- 43 min), 100 – 10 % B (43 - 53 min), 10 % B (53 - 60 min). The flow rate 
was maintained at 1 mL/min and the column effluent was monitored at 214 nm and 
280 nm.  
 
4.9. Flow cytometry 
 
Cell viability was determined by flow cytometry as described in [108]. The 
formation of intracellular ROS was measured employing 2′,7′-dichlorfluorescin 
diacetate (DCFH-DA), as described in [109, 110]. Cells were analyzed on an Epics 
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XL-MCL (Beckman Coulter Inc., USA) with a 488 nm Argon laser. Using BD 
FACSFlow as the sheath fluid, 2×104 cells (events) were measured per analysis. 
Propidium iodide (PI) dye could penetrate only cells with leaky membranes and 
bind to DNA, exhibiting fluorescence with excitation at 480 nm and an emission 
maximum at 630 nm. Viable cells are able to deacetylate DCFH-DA to 2′,7′-
dichlorfluorescin (DCFH), which is not fluorescent. Upon activation of the cell 
oxidative burst, DCFH is rapidly oxidized to highly fluorescent 2′,7′-
dichlorfluorescein (DCF) in the presence of the generated ROS. DCF remains 
trapped within the cell and emits a green fluorescent signal that is measured to 
provide an index of intracellular ROS formation. Harvested cells were centrifuged 
to remove the supernatant. Afterwards, 5 µL DCFH-DA (20 mmol/L in DMSO, 
stored at −20 °C) was added to 1 mL of the cell suspension diluted with PBS and 
incubated with continuous shaking at 37 °C for 30 min. Then the sample was 
placed on ice to stop any reactions. At 2 min before reading, 6 µL PI (1 mg/mL) 
was added in the sample and analyzed. Samples were treated with heat over a flame 
to generate positive dead cells. To create ROS positive controls, oxidative activity 
was stimulated with Di-tert-butyl peroxide (DTBP) to a final concentration of 100 
µM, incubating cells suspension at 37 °C for 1 hour. The labeled cells were excited 
at 488 nm and the emitted light was collected through a 520/30 nm band-pass filter 
(FL1, for DCF) and a 630/30 nm BP filter (FL3, for PI). 
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5. Results 
5.1. The unfolded protein response (UPR) in Pichia 
pastoris cultures 
 
The unfolded protein response (UPR) of Pichia pastoris cells containing the Insulin 
precursor insert (X33-IP) and host strain (X33) during the execution of a two-stage 
fed-batch process was the focus of the investigation in this thesis section. For a 
detailed study, the first and the second cultivation stages - glycerol batch and 
methanol fed-batch phase, respectively - were initially investigated separately and 
afterwards jointly for a comprehensive understanding. The first stage, known as 
glycerol batch phase (GBP), consisted of a batch process with high initial glycerol 
concentration in low salt defined medium where Pichia pastoris cells were allowed 
unlimited growth until depletion of carbon sources. The second stage, the methanol 
induction phase (MIP), consists of a fed-batch process in which the secretory 
production of Insulin was induced. UPR investigations during the MIP were 
performed employing a shake flask fed-batch protocol where methanol was 
induced at an every 12 h interval for a period of 96 h. This protocol enabled the 
study of three parallel methanol induced culture conditions started, however, from 
the same bioreactor glycerol batch. Afterwards, cells UPR was investigated in 
bioreactor methanol feedback controlled fed-batches in order to study the 
physiological response of the producing strain in industrial relevant culture scale. 
Cells were grown in a glycerol batch, induction with different methanol 
concentrations were performed at the “DO-spike”, and the feedback fed-batches 
were controlled in closed loop by a proportional-integral-derivative (PID) 
controller in response to a flame ionization detector (FID).  
Refer to Appendix I, section 9.2, 9.3 and 9.4 for parameter details of an entire two-
stage fed-batch cultivation, purification and HPLC quantification, respectively, 
performed to obtain Insulin precursor lyophilized powder employed in the entire 
thesis as standard for IP quantification curves.  
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5.1.1. Downregulation of UPR during bioreactor glycerol batch 
phase 
 
Non-carbon limited batch cultivations with P. pastoris producing and non-
producing strains were studied, monitoring cellular physiological response, with 
special focus to the unfolded protein response (for details on the host strain 
cultivation, refer to section 10.1). The metabolic state of the cells was accessed by 
examining small fluctuations of proteins containing the HDEL ER retention 
peptide using an anti-HDEL antibody, which is present in the main UPR response 
target protein Kar2. Figure 5.1.1– A shows the SDS-PAGE gel with samples 
normalized by OD600, collected during the entire glycerol batch phase and Figure 
5.1.1 – B illustrates the same lysate samples electro-blotted onto a PVDF 
membrane, stained for a controlled time period after incubation with specific anti-
bodies. These images were employed in the Kar2 relative quantification 
densitometry analysis described in detail in the Methods section 4.6.4. For a 
comprehensive analysis of the batch process, after the end of the exponential phase 
cells were allowed to enter the stationary phase and the intracellular amount of 
Kar2, the main marker for UPR, was monitored during the entire process (Figure 
5.1.1 – C). The growth related protein aggregation prevention phenomenon seems 
to be differently regulated during the applied non-carbon limited batch cultures. 
After early adaptation (Lag phase), cells start consuming glycerol and the growth 
related Kar2 biosynthesis gets fully activated by cells entering the exponential 
growth phase (Figure 5.1.1 – B and C). In time, cellular growth declines and is 
followed by a decrease in the Kar2 amount. When compared to initial exponential 
growth phase values, intracellular Kar2 presented a ~5 fold and ~20 fold decrease 
in the declining growth phase and stationary phase, respectively, (Figure 5.1.1 – C). 
No Kar2 could be detected in the extracellular fraction of the producing or non-
producing strain during the entire batch growth in glycerol (for the host strain SDS 
gels refer to Figure 10.1.1 – B and D).  
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Figure 5.1.1 – Time course analysis of the bioreactor glycerol batch from Pichia pastoris X33-
IP cells. 
(A) Intracellular lysates fractions from P. pastoris X33-IP analyzed by 12 % SDS-
PAGE. (B) Intracellular lysates fractions from P. pastoris X33-IP probed for proteins containing the 
endoplasmic reticulum retention signal peptide HDEL (e.g. Kar2, 74 kDa) by Western blot analysis. 
All lysate loaded samples were normalized at OD600 50 and extracellular fractions were directly 
applied. (C) Abundance changes of UPR related protein Kar2 are given in relative units 
corresponding to Western blot densitometry analysis, the optical density, and extracellular glycerol 
concentrations and osmolarity during glycerol batch. The sample at 12h was the first with enough 
cell pellet which allowed intracellular fraction examination.The vertical dashed lines highlight the 
growth phases during glycerol batch process. The M lane denotes the molecular weight marker. The 
highlighted Kar2 relative abundance quantification dotted and dashed bars in (C) stand for the 
respective time points Western blot bands in (B). 
 
5.1.1.1. High Kar2 abundance in exponentially growing cells 
 
The burden of growth in a recombinant-protein-free environment was further 
investigated in Pichia pastoris X33-IP cells employing the same low salt defined 
medium containing four different glycerol concentrations, as indicated in Table 
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5.1.1. Considering that glycerol is a trihydroxy sugar alcohol, the increase in media 
osmolarity, measured by a freezing point osmometer, correlates positively with 
increasing glycerol concentrations (Figure 5.1.2 and Table 5.1.1). It is important to 
report that media osmolarity values decreased during the batch phase parallel to 
glycerol decline, caused via cellular consumption (Figure 5.1.2). Furthermore, it is 
viable to speculate that lower glycerol concentrations favored cellular growth, since 
the highest maximal specific growth rate (µmax) was achieved under the lowest 
initial glycerol concentration (30 g/L) (Table 5.1.1).  
 
 
Figure 5.1.2 – Media osmolarity decreases concomitant to glycerol reduction. 
Time course analysis of media osmolarity (A) and glycerol concentrations (B) during Pichia 
pastoris X33-IP batch phase cultivations. Identical symbols in Figure A and B correspond to the 
same batch conditions. 
 
Although promising expectations emerged that increased medium osmolarity 
would result in increased biosynthetic capacity, through the presence of augmented 
Kar2 levels, the findings pointed rather to other conclusions. It seems that the UPR 
is equally highly activated in exponentially growing cells regardless of strain and 
the initial glycerol concentrations employed, ranging from 30 to 125 g/L. For better 
comprehension, the Western blot bands in Table 5.1.1, from the respective 
exponential growth phase (as defined in Figure 5.1.1 – C) of each different glycerol 
concentration applied and strain, were quantified for Kar2 relative abundance as 
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previously. The Pichia pastoris culture conditions studied, presented very similar 
relative intracellular Kar2 abundance during exponential growth phase (Table 
5.1.1), further illustrated by the proximity of each Kar2 relative amount to the 
calculated average of 19. Moreover, identical UPR downregulation time profile 
observed during X33-IP 95 g/L glycerol batch growth (Figure 5.1.1) was detected 
for all the glycerol conditions and producing or non-producing strains described in 
Table 5.1.1 (detailed X33 host strain UPR downregulation: Figure 10.1.1).  
 
Table 5.1.1 – Comparison of Pichia pastoris batches with different glycerol concentrations 
 
* Results are an average of duplicate experiments. 
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5.1.2. Independence of prior to induction Kar2 levels on secretory 
IP production                                                                        
 
So far, the observations have illustrated that exponentially growing cells present 
UPR activation prior to recombinant protein induction, regardless of initial medium 
osmolarity, glycerol concentration and strain, and that this folding response is 
downregulated during growth time course. The synthesis of UPR related proteins 
prior to induction have been suggested to precondition P. pastoris cells for more 
effective IP secretion [4]. To investigate if this “more constitutive” UPR induction 
influenced the recombinant protein production, 10 L glycerol bioreactor batch 
cultivations of P. pastoris X33-IP and X33 (host strain culture details in section 
10.1) were performed, harvesting the X33-IP cells at three different growth 
moments corresponding to high, medium and low constitutive Kar2 (highlighted 
rectangles in Figure 5.1.1 – B whose relative Kar2 band abundance are represented 
by the bars in the left side of the dashed line in Figure 5.1.3 – B) and shifting them 
directly to methanol induction phase in shake flasks. This protocol enabled the 
study of three parallel cultures induced with different initial intracellular Kar2 
amount, grown, however, in the same original 10 L glycerol batch. The induction 
with 1% (v/v) methanol at every 12 h intervals for a period of 96 h was performed 
to simulate a fed-batch process.  
In line with previous results [4], an expected decline in Kar2 intracellular levels, 
until almost undetectable amounts, occurred right after methanol induction in both 
strains (X33-IP and X33 Figure 5.1.3 – A). An immediate UPR decrease was even 
observed in exponentially growing cells, which presented at induction time (0h 
methanol feed) the highest amount of batch produced intracellular Kar2 
(abundance bar in the left side of the dashed line in Figure 5.1.3 – B). Furthermore, 
concomitant to the Kar2 intracellular drop after methanol induction, increase of the 
chaperone detected levels in the extracellular fraction of the producing strain (X33-
IP) occurred simultaneously to the uprising secretion of Insulin precursor (IP) 
(Figure 5.1.3 – A and C). The increasing levels of extracellular Kar2 in the X33-IP 
producing strain are represented by the relative abundance quantification shown in 
Figure 5.1.3 – B. 
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The Kar2 relative abundance analysis allowed the further observation that after 
methanol induction the biosynthesis of freshly produced Kar2 takes place. 
Considering the respective amount of batch produced intracellular Kar2 at 
induction time as an initial reference for each growth phase, the upper part of the 
abundance bars above the horizontal dotted lines in Figure 5.1.3 – B represent the 
de novo synthesized Kar2 during methanol induction phase. It is viable to speculate 
that all freshly produced Kar2 was able to fold the Insulin precursor correctly, 
however failed to unbind from the zymogen and both were secreted as a Kar2/IP 
complex, as already reported [111].  
Additionally, the time course production of secretory Insulin precursor in shake 
flasks was analyzed for the differently UPR preconditioned cultures (Figure 5.1.3 – 
C). Cells from the bioreactor batch culture harvested at the stationary growth 
phase, where the lowest batch related intracellular Kar2 amount was detected, 
presented the highest secretory Insulin precursor production in shake flasks (Figure 
5.1.3 – C), not evidencing a positive correlation between the batch-produced Kar2 
and secretory IP production.  
Taken together, these observations and the fact that the non-producing strain 
presented no Kar2 expression neither in the intracellular or extracellular fraction 
after methanol induction (Figure 5.1.3 – A and Figure 10.1.1), indicate that Kar2 is 
not needed for cellular maintenance on methanol containing media during the 96 
hours observed. Hence, for the IP producing strain, it seems that independently of 
the level of UPR prior to induction, the secretory IP production reactivates the 
biosynthesis of Kar2 and all fresh chaperones were directed to recombinant 
proteins folding.   
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Figure 5.1.3 – Monitoring Kar2 in the intracellular and extracellular fractions of methanol 
fed-batch phase in shake flasks of P. pastoris cells harvested at different glycerol growth phase 
and time course analysis of secretory Insulin precursor production. 
(A) Sections of Western blot analysis of intracellular crude cell lysate and extracellular supernatant 
from producing and non-producing cells probed for proteins containing the endoplasmic reticulum 
retention signal peptide HDEL (e.g. Kar2, 74 kDa). Samples were taken at the indicated glycerol 
batch phase and at 0, 24, 96 hours after methanol induction. The bands inside the highlighted 
rectangles indicate the intracellular Kar2 amount at methanol induction time. All lysate loaded 
samples were normalized at OD600 50 and extracellular fractions were directly applied. (B) 
Intracellular and extracellular abundance changes of the UPR related protein, Kar2, are given in 
relative units corresponding to an average of the resulting values from duplicate gels images. All 
Kar2 amounts above the dotted horizontal line stand for freshly synthesized chaperone. The 
abundance bars at the left side of the dashed vertical line indicate the intracellular Kar2 amount 
present during glycerol batch. (C) Time course analysis of secretory Insulin precursor production in 
shake flasks quantified by HPLC from cells harvested at different glycerol growth phase. The 
average and standard error from two independent experiments are shown. 
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5.1.3. Influence of methanol concentration on Kar2 secretion 
during bioreactor feedback controlled fed-batches 
 
Pichia pastoris X33-IP cells were grown employing the two-stage bioreactor fed-
batch procedure. Initially cells were grown in the 95 g/L glycerol and low salt 
defined medium batch procedure followed by the FID feedback controlled 
methanol induced fed-batch phase, under different inducer concentrations: 1.7, 5.0, 
6.8 g/L methanol. The feedback controlled methanol fed-batches were induced at 
the end of each exponential growth phase, when the batch carbon sources were 
depleted and the “DO-spike” was observed. Before evaluating how Kar2 was 
regulated during the different methanol induction phase conditions, its state was 
monitored during the glycerol batches and at induction time. All glycerol batch 
phases from the later methanol induced fed-batches presented the same growth 
related UPR downregulation as described in section 5.1.1 and exemplified by 
Figure 9.2.4. Figure 5.1.4 illustrates that at methanol induction moment all glycerol 
growth phases from the four fed-batch conditions presented comparable 
intracellular Kar2 amounts and complete absence of the chaperone in the 
extracellular fraction.  
 
 
Figure 5.1.4 – Comparison of intracellular and extracellular Kar2 at fed-batch methanol 
induction time. 
Kar2 was analyzed in the intracellular and extracellular fraction of Pichia pastoris X33-IP cells at 
glycerol batch DO-spike – moment of methanol induction – for all four different methanol 
concentration fed-batches. All lysate loaded samples were normalized at OD600 50 and extracellular 
fractions were directly applied. The M lane denotes the molecular weight marker. 
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Thereafter, the evaluation of Kar2 expression level and cellular location during the 
secretory IP producing fed-batch phase was performed. To illustrate the results, the 
previously applied Kar2 relative quantification densitometry technique was once 
again employed, comparing three different bioreactor cultivations, respectively 
with 1.7, 5.0 and 6.8 g/L methanol. Figure 5.1.5 –  A demonstrates that during the 
feedback controlled methanol fed-batch phases employed the intracellular 
abundance of Kar2 decreases until no more chaperone was detected, as observed 
for the producing and non-producing strains in the shake flask fed-batches (Figure 
5.1.3 – A). In addition, it was possible to identify one other protein in the 
intracellular fraction that was recognized by the anti-HDEL antibody in the 
intracellular fraction, possibly protein disulfide isomerase (PDI), ~55 kDa or 
degradation of Kar2 (Figure 13.1.3 – B). The next step was to monitor Kar2 
secretion in the feedback controlled fed-batches. As previously observed for the 
shake flask fed-batches, the extracellular abundance of Kar2 increased with time 
during the feedback controlled methanol fed-batch phases until complete detectable 
intracellular absence was observed (Figure 5.1.5 – A). In all fed-batch conditions 
the extracellular Kar2 increase occurs concomitantly with its intracellular decrease 
and parallel to increasing Insulin precursor secretion (Figure 5.1.5 – A and B). 
Moreover, it seems that the increase of methanol concentration in the methanol fed-
batch phase accelerated Kar2 secretion process (Figure 5.1.5 – A). However, since 
foaming was observed at the highest methanol fed-batch concentration (6.8 g/L) 
applied any correlation between methanol concentration and Kar2 secretion should 
be made cautiously. Furthermore, the comparable intracellular Kar2 amounts at 
induction time (Western blot presented in Figure 5.1.4) were reconfirmed by the 
relative Kar2 quantification technique in Figure 5.1.5 – A (bars in the left side of 
the dashed vertical line). Summarized, these results from the feedback controlled 
fed-batches point out that Pichia pastoris X33-IP cells presented comparable 
physiological response, monitored by intracellular and extracellular Kar2 
quantification, during secretory Insulin production regardless of the cultivation 
procedure employed, shake flask or bioreactor.  
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Figure 5.1.5 – Effect of different fed-batch methanol concentrations on intracellular and 
extracellular Kar2 and on secretory Insulin precursor production. 
(A) Intracellular and extracellular abundance changes of the UPR related protein, Kar2, are given in 
relative units. All Kar2 amounts above the dotted horizontal line stand for freshly synthesized 
chaperone. The abundance bars at the left side of the dashed vertical line indicate the intracellular 
Kar2 amount produced during glycerol batch at induction time. (B) Time course analysis of 
secretory Insulin precursor production quantified by HPLC from cells under different methanol fed-
batch concentrations. The average and standard error from two independent HPLC analyses are 
shown. 
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5.2. Reactive oxygen species (ROS) and cellular viability 
monitoring 
 
The time course study of reactive oxygen species (ROS) and cell viability during 
the Pichia pastoris methanol shake flask fed-batch was performed by flow 
cytometry, firstly comparing two producing and two non-producing strains: the 
intracellular Hepatitis B surface antigen (HBsAg) and the secretory Insulin 
precursor (X33-IP) producing strains and the respective GS115 and X33 host 
strains. Thereafter, the effect of growth related UPR induction on ROS formation 
was studied, employing the X33-IP producing strain grown in 10 L defined 
medium glycerol bioreactor batch harvested at different growth moments: 
exponential phase, declining growth phase and stationary phase.  
 
5.2.1. Augmented ROS in recombinant P. pastoris strains 
 
The comparison between 4 Pichia pastoris strains grown under identical shake 
flask containing complex media conditions enabled the analysis of the effect of 
methanol metabolism and recombinant protein production on cellular oxidative 
stress through ROS formation. The producing strains applied here have been 
successfully employed for the heterologous production of intracellular Hepatitis B 
surface antigen (6 g/L) and the secretory Insulin precursor (3 g/L) [2, 112], where 
proteomic studies showed that the ER-resident production of HBsAg submitted P. 
pastoris cells to higher activation of ERAD and UPR stress responses, when 
compared to the secretory IP [3, 4]. As control, the non-producing his4 auxotroph 
GS115 and the host strain X33 were employed.  
Flow cytometry results indicated that the secretory IP and the intracellular HBsAg 
producing strains presented increased ROS formation under the conditions tested. 
X33-IP and HBsAg cells presented increasing FL1 (ROS) mean fluorescent signal 
intensity during the methanol induction phase, reaching the highest values at 96 h 
after methanol induction (Figure 5.2.1 – A). Since both host strains at 96 h of 
Results  53 
methanol feeding showed lower FL1 fluorescence signal under the same culture 
conditions, it is clear that the effect of heterologous protein production on ROS 
formation is higher than methanol metabolism, in spite of its basal increase over 
time. Unexpectedly, despite of having to cope with a larger and complex product, 
the HBsAg producing strain presented slightly higher FL1 mean signal intensities 
than the GS115 host strain in both cultivation repetitions, whereas the X33-IP 
producing strain showed  ~3.5 fold average fluorescence signal increase relative to 
the X33 non-producing strain, indicating augmented ROS formation throughout 
secretory heterologous protein production. Furthermore, the strains presented high 
viability (> 93 %) and relatively constant OD600 values during the entire methanol 
induction phase (Figure 5.2.1 – B and C). 
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Figure 5.2.1 – ROS, viability and optical density of 4 different Pichia pastoris strains. 
Pichia pastoris shake flask fed-batch cultures of GS115, X33, HBsAg and X33-IP cells were 
monitored and compared during the methanol induction phase for reactive oxygen species (ROS) 
formation (A), cellular viability (B) and optical density at 600 nm (C). Fluorescence signal intensity 
for ROS (FL1) and viability (FL3), monitored by flow cytometry, were carried out by double 
staining with DCF and PI, respectively. Cells were first grown in complex media containing 
glycerol to generate sufficient biomass, harvested, centrifuged and re-suspended in three shake 
flasks with fresh methanol containing media. Cultivations with the 4 strains were performed two 
times independently and the pattern inside the bars indicates repetition experiments. The average 
and standard error from the methanol induction phase of each strain’s triplicate shake flasks 
experiments are shown.  
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5.2.2. General ROS increase in P. pastoris X33-IP cells induced at 
different growth times 
 
The study of ROS formation of Pichia pastoris X33 secreting Insulin precursor 
(X33-IP) was performed employing the previously described methanol shake flask 
fed-batch protocol, with cells harvested from a 10 L defined medium glycerol batch 
at different growth moments. Induction with 1% (v/v) methanol at every 12 h 
intervals for a period of 96 h was performed to simulate a fed-batch process. A 
general FL1 mean fluorescence signal (ROS) increase was observed during the 
methanol induced secretory IP production shake flask fed-batch independent of the 
different glycerol growth moment which they were induced (Figure 5.2.2 – A). 
Results point out that augmented ROS is equally increased independently of the 
UPR activation during glycerol batch prior to methanol induction. During the entire 
shake flask fed-batch process cells presented very high viability values, > 98 % 
(Figure 5.2.2 – E). At time point 0 h cells presented the lowest ROS amounts 
(Figure 5.2.2 – A). In time, cells adapt to the methanol containing media, arresting 
growth, (stabilizing OD600, Figure 5.2.2 – D), metabolizing the substrate through 
the dissimilation pathway and the secretory production of Insulin precursor (Figure 
5.2.2 – F). In the first 24 h the highest residual methanol was found (Figure 5.2.2 – 
B), thereafter cells consume it per shake flask (~37 mL culture medium) in a rate of 
~15 g/day (Figure 5.2.2 – C). It should be noted that the shake flask protocol 
employs the induction of 1 % (v/v) methanol at every 12 h intervals for a period of 
96 h. The highest ROS formation was detected, as expected, after 96 h, the end of 
the methanol shake flask fed-batch cultivation (Figure 5.2.2 – A). At this point, the 
highest levels of secretory Insulin were also detected (Figure 5.2.2 – F). 
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Figure 5.2.2 – Methanol shake flask fed-batches time course monitoring and comparison of 
X33-IP cells. 
Pichia pastoris X33-IP shake flask fed-batch cultures of cells harvested at exponential growth, 
declining growth and stationary growth phases were monitored and compared during the methanol 
induction phase for reactive oxygen species (ROS) formation (A), supernatant residual (B) and 
consumed (C) methanol concentration, optical density at 600 nm (D), cellular viability (E) and 
secretory Insulin precursor production by HPLC (F). Fluorescence signal intensity for ROS (FL1) 
and viability (FL3), monitored by flow cytometry, were carried out by double staining with DCF 
and PI, respectively. Cells were firstly grown in complex media containing glycerol to generate 
sufficient biomass, harvested, centrifuged and re-suspended in three shake flasks with fresh 
methanol containing media. The average and standard error from the methanol induction phase of 
each condition’s triplicate shake flasks experiments are shown.  
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6. Discussion 
 
The increasing need for biopharmaceuticals is a fact which is represented by its 
every year growing market. This ever rising demand has to be attended with state 
of the art technique. Pichia pastoris has a remarkable success story over the past 
three decades due to its unique characteristics; among them its high secretory 
capacity, the ability to grow into high biomass, possibility of human like 
glycosylation, controllable recombinant protein promoter. In spite of all this 
advantages, there is still limited knowledge on how stress responses during the 
production of proteins such as Insulin, vaccines or others are affecting the final 
productivities and the recombinant product quality. Stress responses are a broad 
subject which demands careful attention. The study of physiological responses of 
Pichia pastoris has been the interest of our research group for some years now. 
Firstly, the biotechnological process development was performed for intracellular 
production of Hepatitis B surface antigen (HBsAg) and thereafter for the secretory 
production of Insulin precursor (IP) employing two-stage fed-batch bioreactor 
cultivation with Pichia pastoris GS115 and X33, respectively [2, 112]. Afterwards, 
a general study of the cells physiological response was performed employing 2D 
gels proteomics technique. A difference in the cells response depending on the 
recombinant protein produced was reported [3, 4]. Interestingly, while producing 
the small molecule of IP Pichia pastoris cells did not present the expected ER 
stress response as they did during the recombinant HBsAg production. This 
discrepancy between stress response depending of the product produced and 
cellular state prior and after induction, rose several questions which were the focus 
of the work presented in this thesis. Furthermore, surprisingly little attention has 
been given to the yeast physiological state prior to induction, independent of the 
production of aberrant proteins. Therefore, to attend these questions, the unfolded 
protein response in Pichia pastoris X33 cells producing and non-producing 
secretory Insulin precursor was studied in detail. The cultivation phases – the 
glycerol batch and the methanol fed-batch – were initially studied separately and 
thereafter in a comprehensive manner where the effect of one phase upon the other 
was the subject of study.  
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The commercially available operational manual for fed-batch growth of Pichia 
pastoris, originally developed for the Mut- strain [113], undergoes three different 
fermentation phases. A glycerol batch phase (GBP), a mixed-feed transition phase 
(TP) and finally a methanol induction phase (MIP). The alternative fermentation 
techniques developed by our research group excluded the TP, employed the Mut+ 
strain obtaining high-level protein expression [2, 112]. The modified two-phase 
fed-batch procedure for the secretory production of Insulin precursor (IP) [2], 
originally developed for high-level intracellular production of Hepatitis B surface 
antigen (HBsAg) with P. Pastoris GS115 [112], was further optimized by 
employing the bioreactor defined medium in the pre-cultures, obtaining more 
reproducible growth curves prior to main culture inoculation (Appendix I, section 
9.1). The production of Insulin precursor purified powder, to be used as a reference 
during the entire thesis, was performed by cultivating the inoculum preconditioned 
Pichia pastoris cells containing the Insulin precursor insert (X33-IP) in the 
industrial relevant fed-batch approach [2]. In this system, usually applied for large 
scale production of recombinant proteins, cells were initially transferred into batch 
defined medium containing high glycerol concentrations and low to moderate salt, 
resulting in high initial osmolarities, and grown until high biomass prior to 
induction of recombinant proteins (Figure 5.1.1 and Appendix I, section 9.2). The 
successful production and purification of IP enabled its use as a quantification 
standard during the entire thesis (Appendix I, Figure 9.2.2, Figure 9.2.3, Figure 
9.3.1 and Figure 9.4.1). 
Downregulation of Kar2 throughout glycerol batch phase 
The occurrence of inherent protein misfolding incidents during cellular growth [38] 
requires quality control systems. As an integral part of the ER surveillance 
machinery, Kar2 binds more persistently to misfolded or unassembled proteins and 
prevents them from exiting the ER [36]. In spite of the attenuation of the immediate 
osmotic stress, which can cause temporary growth arrest [93], by preconditioning 
cells in defined medium pre-culture, metabolic adaptation results were obtained 
monitoring the UPR marker Kar2 intracellular levels. The growth related unfolded 
protein response seems to be differently regulated during the applied non-carbon 
limited glycerol batch cultures independently if the Pichia pastoris strain X33 
carried or not the secretory Insulin precursor insert (Figure 5.1.1 and Figure 10.1.1) 
Discussion  59 
or on how high the initial defined medium glycerol concentrations were (Table 
5.1.1). Taking in account that studies demonstrated that UPR markers (e.g. Kar2) in 
Pichia pastoris wild type strains were ~3 fold upregulated in ionic compounds 
induced high osmolarity when compared to low osmolarity conditions [95], thus 
the high Kar2 amount for both strains in this work during exponential growth phase 
was thought to be related to the elevated initial osmolarity caused by high glycerol 
concentration in culture medium. This hypothesis however was ruled out by the 
results obtained from the batch cultures containing different initial glycerol 
concentrations. Indeed, employing variable glycerol concentrations different 
osmolarity values were obtained (Figure 5.1.2), however the same initial relative 
abundance of Kar2 at exponential phase and UPR decrease during batch cultivation 
time course were observed for all glycerol conditions employed (Table 5.1.1). This 
could mean that cells present an equal and maximal biosynthetic capacity, 
measured by monitoring Kar2, to undergo growth in defined medium containing 
glycerol. On the other hand, recent reports account for UPR induction, by 
upregulation of HAC1, also a UPR marker, and its primary targets, with increasing 
specific growth rate (µ) as one major regulatory reaction to increasing cellular 
proliferation [83]. Therefore the observed high relative abundance of Kar2 for all 
glycerol conditions during the initial exponential phase hours presented in Table 
5.1.1 would be due to an overlapped effect caused by osmolarity and specific 
growth rate. Since, while under low initial glycerol concentrations, consequently 
low medium osmolarity, cells achieve a higher maximal specific growth rate (µmax), 
and vice-versa, the effect of osmolarity on UPR could be masked due to the effect 
of growth rate in UPR. Furthermore, the disappearance of intracellular Kar2 during 
the stationary growth phase could indicate a phenomenon called ER-phagy [114-
116]. Autophagy is a normal physiological process to maintain cellular homeostasis 
that occurs during extended cultivation periods and under other conditions, and 
Ribophagy – degradation of ribosomes - and Pexophagy – degradation of 
peroxisomes - have been already observed in Pichia pastoris growing under 
different conditions [3, 114, 117-119]. The process of engulfing the ER and target 
it to degradation, would explain the disappearance of the ER-resident chaperone 
Kar2 during the batch stationary phase of growth, as observerd by Zhong et al. 
[114], however this phenomenon has to be further investigated to avoid any early 
conclusions.  
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Independence of prior to induction Kar2 levels on secretory IP production 
There is some evidence that exposure to osmotic stress can have a beneficial effect 
on recombinant protein production in bacterial, yeast and mammalian host 
organisms, however this effect, at least in mammalian cells, is often cell line 
specific [90, 95, 120-122]. Additionally, it is already known that extrapolation of 
environmental conditions, such as cellular nutritional state [36], methanol 
concentration in the MIP [4] and temperature [85], could force the yeast cells into 
high levels of ER stress through the activation of the unfolded protein response 
(UPR) and Endoplasmic-reticulum-associated protein degradation (ERAD). 
Regarding the methanol induction phase different levels of stress on the host cell 
may be exerted, depending on the specific features of the overexpressed secreted 
mutant or foreign protein. Not only elevated intracellular levels [3, 111, 123] but 
also increased extracellular secretion of Kar2 [41, 111] have been reported. In the 
case of methanol-induced secretory Insulin precursor production in Pichia pastoris 
X33 there is a decrease of the UPR activity in the intracellular fraction [4]. Since, 
little attention has been given to the cells physiological state prior to induction and 
how relevant is its effect over the production phase, the shake flask fed-batch 
protocol was employed harvesting cells at different growth moments during 
glycerol batch phase and inducing them for the secretory production of Insulin 
precursor. In spite of expectations that UPR preconditioned cells, induced with 
methanol during the exponential growth phase, would favor recombinant protein 
production due to augmented relative Kar2 abundance, results pointed out to other 
conclusions. It seems that the generated UPR during glycerol batch phase does not 
influence the secretion of Insulin precursor (Figure 5.1.3 – C). Actually, Pichia 
pastoris X33-IP cells induced at the stationary phase, which were growth related 
Kar2 absent, produced high amounts of fresh chaperone, and elevated IP 
production and Kar2 secretion during the methanol phase (Figure 5.1.3). 
Furthermore results indicate that this ER chaperone secretion phenomenon is solely 
due to recombinant production since the Pichia pastoris host strain X33 presented 
after methanol induction intracellular and extracellular absence of Kar2 (Figure 
10.1.1). These unexpected results corroborate with the previously reported decrease 
of UPR and ERAD pathways during methanol induced secretory IP production [4], 
as well as, with the non-essentiality for growth of retained Kar2 by the HDEL 
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system [63], as producing and non-producing cells presented high viability values 
(> 98 %) during the entire shake flask fed-batch procedure (Figure 5.2.2 – E). The 
Insulin precursor gene is preceded by the Saccharomyces cerevisiae α-mating 
factor pre-pro-peptide signal leader sequence. This secretion signal seems to work 
fine given that IP has been successfully detected in the culture supernatant during 
the shake flask and feedback controlled fed-batches (Figure 5.1.3 – C, Table 12.1.1 
and Figure 9.2.2 – F). However, this could also be causing Kar2 extracellular 
translocation, given that it has been shown that the Erd2-mediated retention can be 
saturated by overexpression of an HDEL-tagged pro-α-factor or Kar2, and by other 
conditions that activate the UPR (e.g., treatment with β-mercaptoethanol or 
tunicamycin) [63, 64, 111, 124, 125]. These results indicate that the retention of ER 
luminal proteins is complicated and still unsolved mechanism, which does not 
strictly depend only on HDEL/KDEL sequences, but is likely a combination of 
several factors. 
Augmented ROS throughout recombinant protein production 
Studies on Saccharomyces cerevisiae showed that in addition to upregulate the 
know UPR targets, the Ire1-HAC1 pathway also activated some anti-oxidative 
stress genes, possibly in order to reduce reactive oxygen species produced during 
the cellular response to ER stress, suggesting a protective “side-effect” action of 
this pathway on oxidative stress [75, 126]. Considering that recombinant protein 
production may also induce ER stress, an imbalance between heterologous protein 
folding and disulfide bond formation rates in S. cerevisiae were proposed to lead to 
production of augmented ROS, through many glutathione peroxidise (Pmp20) 
mediated futile redox cycles [101]. Indeed, augmented ROS was observed solely in 
the IP and HBsAg producing strains (Figure 5.2.1 – A), indicating a clear higher 
effect of heterologous protein production compared to methanol metabolism on 
ROS. Never the less, in the work of Vanz et al. [3] after methanol induction in 
HBsAg and IP production a strong upregulation of Cta1, an enzyme involved in the 
removal of H2O2, was observed for both strains, whereas Pmp20 increase was only 
observed for the first. Thus, illustrating the importance of correct detoxification 
function of these enzymes involved in methanol metabolism, considering that ROS 
can give rise to a significant degree of oxidative stress and even induce UPR if the 
level of PDI substrates is sufficiently high [75, 82]. Furthermore, other studies have 
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also demonstrated an unexpected protective effect of UPR over oxidative stress. 
Higher ROS levels were detected in P. pastoris cells with activated UPR 
expressing intracellular recombinant human interleukin-10 cultivated at 30 °C 
compared to ER-phagy absent cells grown at 20 °C [114]. A similar defensive 
effect of UPR on ROS formation was suggested by flow cytometry results in this 
thesis. A stronger increase in reactive oxygen species during the methanol induced 
shake flask fed-batch protocol independently of UPR activation prior to induction 
solely in the secretory Insulin precursor producing strain was observed when 
compared to the HBsAg producing strain and to their respective host strains, X33 
and GS115 (Figure 5.2.1 – A and Figure 5.2.2 – A). The HBsAg producing strain 
unexpectedly presented slightly increased ROS levels compared to the non-
producing strain. Concerning stress responses of HBsAg and IP producing strains, 
published studies under similar conditions pointed out for different cellular 
physiological responses. While producing high amounts of ER-resident HBsAg 
cells presented high intracellular ERAD and UPR activation [3]. On the other hand, 
during IP secretion an intracellular decrease of UPR- and ERAD-related proteins 
was observed [4], in accordance with results presented here, however with the 
additional observation of Kar2 presence in the extracellular fraction (Figure 5.1.3). 
Moreover, since both strains did not significantly grow after methanol induction 
Figure 5.2.1 – C, the reported unfolded protein response can be assumed 
exclusively due to recombinant protein production. These results allow the 
speculation that since IP producing cells secrete Kar2 during methanol induction 
phase, they lose their intracellular protein folding capacity, which in turn reduces 
their ability to cope with ROS formation, however the HBsAg producing cells 
produce high amounts of intracellular recombinant protein, activating the folding 
machinery and ultimately the UPR, but since Kar2 remains intracellular [127], cells 
can cope with folding, matching the disulfide bonds formation therefore protecting 
cells and not generating ROS.  
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7. Conclusions and outlook 
 
The unfolded protein response in Pichia pastoris X33 cells producing and non-
producing secretory Insulin precursor was studied primarily by analyzing the Kar2 
relative abundance independently in each phase of the bioreactor cultivation, the 
glycerol batch and the methanol fed-batch. Later on the impact of the first on the 
second phase was the object of investigation. Collectively the results point out that 
Pichia pastoris Kar2 chaperone participates in two distinguishable cellular 
functions. Under biotechnological relevant batch growth, where high initial 
extracellular osmolarity due to elevated concentrations of the non-fermentative 
carbon source glycerol, the host cell and the producing strain presented an 
overlapped constitutive activation of the UPR machinery prior to induction of 
recombinant proteins. The need to overcome the inherent misfolding caused by 
rapid growth in the hyperosmotic environment applied fully activates the cellular 
biosynthetic capacity at early exponential growth phase. After initial growth arrest 
and adaptation to batch environment, both strains undergo identical time course 
downregulation of the main UPR marker, Kar2. After methanol induction, host 
cells and IP strain undergo different UPR regulation regardless of identical 
biosynthetic response caused by growth in glycerol batch. The absence of 
intracellular and extracellular Kar2 in the host strain reveals the unneeded 
chaperone presence for cellular maintenance during methanol cultures. On the 
other hand, all freshly synthesized Kar2 by the producing strain was directed to 
folding of secretory Insulin precursor. Moreover, the batch UPR constitutive 
preconditioning had no positive correlation with the secretory Insulin precursor 
production. Taken together, these observations lead to the conclusion that cells 
undergo two different UPR related activations. One is a time course decrease 
occurring prior to the production of recombinant proteins throughout the glycerol 
batch phase, where at initial exponential growth phase high Kar2 levels were 
detected supposedly due to an overlapped effect of rapid growth and osmolarity. 
The other folding response happens when cells are shifted to methanol-induced 
secretory Insulin precursor production, where Kar2 is freshly synthesized and 
secreted together with correctly formed Insulin precursor. Furthermore, studies 
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carried out monitoring ROS levels of secretory IP and intracellular HBsAg 
producing strains and their respective host strains indicated a stronger effect of 
heterologous protein production compared to methanol metabolism on reactive 
oxygen species. 
The future prospects to this work covers firstly the clarification of the mechanisms 
involved in the Kar2 disappearance during the late stage of the declining growth 
phase and stationary phase. Further studies should indentify, perhaps through 
electron microscopy images or by identification of an alternative ER marker, 
whether if during extended batch periods, when nutrients became scare, cells 
undergo the selective autophagic process, identified as ER-phagy [114], and if so, 
how Pichia pastoris yeast regulates this autophagic process. Secondly, future 
studies should concentrate on the ER-resident chaperones translocation during the 
methanol fed-batch phase. Efforts should contemplate not only the intracellular end 
extracellular translocation of the HDEL tagged proteins, but also their CopI 
mediated transport from the Golgi apparatus to the ER. Furthermore, the study of 
alternative substrates and perhaps, the induction of hyperosmolarity through ionic 
osmolytes would help to clarify, independently, the relation between growth rate 
and medium osmolarities results observed in this work for Pichia pastoris X33 
cells during glycerol batch. Thirdly, the speculated protective “side-effect” of UPR 
activation due to recombinant protein production should be further investigated. 
While “unprotected” UPR decreased IP producing cells presented rising ROS 
levels during the methanol induction phase, the ER-stressed HBsAg producing 
cells unexpectedly cope with the oxidative stress during fed-batch phase, 
supposedly due to the ongoing intracellular recombinant protein related UPR. 
Proteomic studies should perhaps focus on the detection of Pmp20, the glutathione 
peroxidise, during secretory IP production, and extra effort should be placed on the 
transcriptional regulation analysis of Yap1, a transcription factor involved in the 
glutathione redox system [128, 129], applying RT-PCR with specific primer to 
monitor its anti-oxidative role. Concluding, the summed up current 
biotechnological relevant yeast data presented here might be used in future strain 
and bioprocess engineering development considering the diversity in which the 
Pichia pastoris unfolded protein response was studied. 
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9. Appendix I 
9.1. Composition of inoculum culture media 
 
The usual approach applied for controlled cellular bioreactor processes requires a 
sequence of upscaling pre-cultures. This concept is necessary to generate an 
adequate number of cells for inoculation of the production bioreactor. Generally, 
inoculum cultures are composed of complex medium, which contains an undefined 
mixture of carbon and nitrogen sources, such as yeast extract or casein hydrolysate. 
The unknown proportion of complex ingredients can interfere in experimental 
homogeneity, nevertheless it is widely used. On the other hand, to achieve higher 
reproducibility, media containing defined amount of ingredients can be employed. 
Pichia pastoris cells producing secretory Insulin precursor (X33-IP) were grown in 
shake flasks in the commonly applied complex medium and its optical density time 
course was compared to those obtained from cells grown in defined media 
containing 10, 25, 75 or 126 g/L glycerol as sole carbon source in shake flasks. As 
the standard error in Figure 9.1.1 illustrates, under the applied conditions all 
defined media cultures presented lower optical density heterogeneity values when 
compared to the complex medium culture. Moreover, X33-IP cells in the culture 
containing 25 g/L glycerol in defined medium (Figure 9.1.1 – B) were able to grow 
until higher OD600 in more suitable time. Taken together, these results point out 
that the most appropriate composition of inoculum medium which was employed in 
the bioreactor cultivations was the defined medium with 25 g/L glycerol.  
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Figure 9.1.1 – Optical density time course comparison of P. pastoris X33-IP grown in different 
inoculum media in shake flasks.  
P. pastoris X33-IP cells were grown in commonly used complex medium as well as in defined 
media containing the indicated glycerol concentrations in shake flasks. The average and standard 
error from two independent experiments are shown.  
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9.2. Application of a two-phase fed-batch process for 
Insulin precursor production 
 
A robust two-phase feedback controlled fed-batch was successfully employed for 
obtaining secretory Insulin precursor in Pichia pastoris X33-IP 5 L bioreactor 
cultures. Cells grown in the inoculum containing the defined medium described 
previously were transferred into the bioreactor and the batch phase was initiated. 
Cells grew exponentially until complete depletion of the carbon source (Figure 
9.2.2 – A), indicated by strong drop in the respiration rates, as well as, an expected 
decrease in the agitation values (Figure 9.2.2 – D and E). Curiously, while cells 
grew aerobically consuming glycerol, the production of ~0.4 g/L ethanol was 
detected by the FID (Figure 9.2.2 – B) and confirmed by gas chromatography. 
Furthermore, at the end of the batch phase a cellular metabolic change takes place 
indicated by the interruption of ammonia solution addition and sudden increase in 
phosphoric acid addition (Figure 9.2.2 – C). At this point, the methanol induction 
phase was started (vertical dashed line in Figure 9.2.2) and ~2 g/L methanol 
concentration was maintained during the entire fed-batch process (Figure 9.2.2 – 
B). Successful cellular adaptation to the methanol levels was noticeable by a slight 
decrease in culture pH followed by base addition for culture pH maintenance and 
increase in the respiratory activity (Figure 9.2.2 – C and E). The biomass 
concentration showed only a slight increase after the shift to methanol, increasing 
from 36 to 40 g/L and starting to decline again after about 150 h growth on 
methanol (Figure 9.2.2 – A). Aeration was kept at 3.5 L/min throughout the 
process. 
The de-repression of the strong and tightly regulated methanol-inducible alcohol 
oxidase 1 promoter (PAOX1) was confirmed by 12 % SDS-PAGE analysis (Figure 
9.2.3 – A). The presence of alcohol oxidase 1 (Aox1), a major protein required for 
methanol utilization, which was only present in minor amounts during growth on 
glycerol, started to increase after 13 h of methanol feeding phase onset, and 
accumulated until the end of the fed-batch process (Figure 9.2.3 – A).  The 
production and secretion of IP during the methanol induction phase from culture 
aliquots withdrawn at various time points was confirmed by RP-HPLC and by 16 
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% SDS-PAGE (Figure 9.2.2 – F and Figure 9.2.3 – B, respectively). As expected, 
at methanol induction (0 h), there is no Insulin precursor in the cell-free 
supernatant (Figure 9.2.3 – B). Extracellular IP concentrations increased until 230 
h of cultivation, reaching a maximum of 1.15 grams of Insulin precursor per liter of 
cell-free supernatant. Degradation of IP was not observed during the whole 
process. Figure 9.2.4 indicates the growth related UPR downregulation during the 
glycerol batch phase. 
The methanol concentration was regulated by a proportional-integrative-derivative 
(PID) controller in response to the on-line feedback signal of a flame ionization 
detector (FID) (Figure 9.2.1). For induction, the desired amount of methanol was 
added to the culture and the FID signal was set. From there on, methanol was 
automatically pumped into the reactor in a closed loop feedback control. The FID 
and PID parameters were set-up in order to receive a good response. FID 
parameters: range = 1000, zero = 3.6 and gain = 9.9. PID controller parameters: 
pump = 32 rpm, min. output = 0.0, max. output =  100.0, deadband = 0.0, XP = 7.0, 
TI (s) = 100.0, TD (s) = 0.1, average time (s) = 0.0, output increment (%) = 100.0, 
set point ramp time (s) = 10.0. The “dead time” from induction until FID stable 
signal at 20 % was ~25 min. Agitation had no influence on FID signal. These 
parameters were employed in all fed-batch experiments. 
 
 
Figure 9.2.1 – Schematic of a closed loop PID feedback controller applied in the fed-batches. 
Appendix I  80 
 
Figure 9.2.2 – Two-phase fed-batch cultivation of P. pastoris X-33 secreting Insulin precursor. 
Cells were first grown in a batch phase with 95 g/L glycerol as carbon source followed by a 
methanol feeding phase (1.7 g/L) to induce the production of IP. (A) Concentrations of glycerol and 
biomass (optical density; DCM) and medium osmolarity. (B) Concentration of methanol and 
amount of methanol added to the bioreactor. A FID detected peak of ethanol produced during 
glycerol batch phase is indicated. (C) Medium pH, amount of ammonium hydroxide, and amount of 
phosphoric acid added to the bioreactor. (D) Dissolved oxygen concentration, aeration rate, and 
stirrer speed. (E) Carbon dioxide production rate, oxygen uptake rate and respiratory quotient. (F) 
Cell growth and extracellular accumulation of IP. The dashed vertical line indicates the end of the 
glycerol batch and the start of the methanol feeding phase. 
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9.3. Insulin precursor purification 
 
Purification was performed following [2] with modifications. Ion exchange 
chromatography was employed using a FPLC system. The IP-loaded Streamline SP 
XL resin was washed with water until the flow through absorbance at 280 nm and 
conductivity values returned to base line (Figure 9.3.1 – A). Following, the bound 
IP was isocratically eluted from the resin using 1 mol/L sodium chloride. The 
column flow through and pooled protein containing fractions, indicated by an 
absorbance at 280 nm peak, were analyzed by SDS-PAGE (Figure 9.3.1 – B).  The 
eluted 10 mL IP-containing pool was dialyzed against 1x PBS buffer and the final 
total protein amount in the sample was 2.77 mg/mL, totalizing 34.6 mg of pure IP. 
Considering that at the time harvested, the cell-free supernatant from the Pichia 
pastoris X33-IP fed-batch cultivation contained ~1000 mg/L Insulin precursor 
quantified by RP-HPLC, the purification recovery was ~7 %. The pure sample was 
lyophilized for further quantification use.  
 
 
Figure 9.3.1 – Streamline SP XL ion exchange FPLC chromatogram and SDS-PAGE 16 % 
purification steps. 
Purification of secretory Insulin precursor in the cell-free supernatant produced during the two-stage 
fed-batch process of Pichia pastoris X33-IP. (A) Ion exchange chromatogram indicating the 
milliabsorbance measured at 280 nm and conductivity values of the eluted protein-containing cell-
free supernatant. (B) Purification steps analyzed by Coomassie stained SDS-PAGE 16 %. The cell-
free supernatant lane stands for the crude extracellular sample, produced during fed-batch, applied 
for interaction with the ion exchange resin. Flow through lanes state for the unbound eluated 
proteins. The 280 nm peak fractions indicate the volume in which the protein pool was collected 
during FPLC elution with 1 mol/L sodium chloride. The concentrated purified Insulin precursor is 
shown in the lane Pure IP after dialysis against 1x PBS. The molecular weight marker is indicated 
by M. 
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9.4. Insulin precursor quantification 
 
Preparations containing different dilutions of the lyophilized powder were used to 
build a standard curve for Insulin precursor quantification. The Insulin precursor 
purified powder was re-suspended in ultrapure water and was quantified for total 
protein content using BCA protein assay kit and BSA as protein reference. 
Different IP dilutions were prepared and their peak area was analyzed by Reversed-
phase HPLC (RP-HPLC). Only one peak was detected by 214 nm absorbance in 
the dilutions chromatogram which corresponded to the purified Insulin precursor. 
The Insulin precursor vs. peak area measured at 214 nm standard curve was built 
and had a linear regressive coefficient of 0.9919 (Figure 9.4.1). The time course 
analysis of IP production during the methanol induction phase (Figure 9.2.2 – F) 
was performed employing the peak areas obtained from the withdrawn fed-batch 
culture aliquots in the linear standard curve equation. To check if none natural 
proteins has the same retention time as Insulin precursor, negative control runs 
were performed with samples from the producing strain X33-IP and X33 host 
strain before and after methanol induction. 
 
 
Figure 9.4.1 –  Purified Insulin precursor quantification curve by RP-HPLC. 
Dilutions of the lyophilized powder from the cell-free supernatant purification produced by Pichia 
pastoris X33-IP fed-batch cultivation versus the integrated peak areas of the purified Insulin 
precursor detected by 214 nm absorbance RP-HPLC. 
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10. Appendix II 
10.1. Pichia pastoris X33 host strain cultivation  
 
Pichia pastoris X33 host strain was cultured in identical conditions as the 
producing strain X33-IP, allowing its use as a negative control for the physiology 
studies performed in this thesis. Firstly X33 cells were grown in a 10 L batch phase 
containing 95 g/L glycerol in the low salt defined medium, afterwards cells were 
harvested from the bioreactor at the DO-spike, when the carbon source was 
depleted, to be finally transferred into fresh methanol containing medium 
employing the shake flask fed-batch protocol. The induction with 1% (v/v) 
methanol at every 12 h intervals for a period of 96 h was performed to simulate a 
fed-batch process.  
Although the bioreactor harvest was performed at the end of the exponential 
growth phase (arrow in Figure 10.1.1 – E), X33 cells from the glycerol batch were 
allowed to grow until the stationary phase to monitor Kar2 levels. The initial high 
osmolarity caused by elevated glycerol medium concentration decreases during the 
X33 host strain batch phase (Figure 10.1.1 – E), as observed for the Insulin 
producing strain under different glycerol conditions (Figure 5.1.2). After harvest 
and inoculation in fresh methanol containing medium, the host strain cells did not 
grow significantly during the shake flask fed-batch (Figure 10.1.1 – E), in 
agreement with that described for the X33-IP producing strain (Figure 5.2.2 – D).  
As described previously, the host strain presented during the glycerol batch phase 
the same growth related UPR downregulation (Figure 10.1.1 – C) as the producing 
strain X33-IP. No Kar2 could be detected in the extracellular fraction of the non-
producing X33 strain at methanol induction time (Figure 10.1.1 – B and D).  In 
spite of the fact that at harvest moment some intracellular Kar2 could be detected 
in the Western blot analysis (43 h of glycerol batch in Figure 10.1.1 – D), the 
intracellular and extracellular absence of Kar2 in the X33 non-producing strain 
during methanol fed-batch (Figure 10.1.1 – D), as published for the other Pichia 
pastoris host strain GS115 [4], indicates that the chaperone secretion phenomena is 
related to recombinant protein production. 
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Figure 10.1.1 – Time course analysis of the 95 g/L bioreactor glycerol batch and shake flask 
fed-batch from Pichia pastoris X33 host cells. 
P. pastoris X33 12 % SDS-PAGE analysis from the glycerol batch phase intracellular lysates (A) 
and intracellular and extracellular fractions from methanol shake flask fed-batch (B). Western blot 
analysis probed for proteins containing the endoplasmic reticulum retention signal peptide HDEL 
(e.g. KAR2, 74 kDa) from the glycerol batch phase intracellular lysates (C) and intracellular and 
extracellular fractions from methanol shake flask fed-batch (D). All lysate loaded samples were 
normalized at OD600 50 and extracellular fractions were directly applied. (E) Abundance changes of 
UPR related protein Kar2 are given in relative units corresponding to Western blot densitometry 
analysis, the glycerol batch and methanol fed-batch phase optical density and batch defined medium 
osmolarity. The sample at 13h was the first with enough cell pellet which allowed intracellular 
fraction examination and was considered reference for Western blot densitometry analysis. The M 
lane denotes the molecular weight marker. The arrow indicates the time of cell harvest for shake 
flask fed-batch inoculation.  
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11. Appendix III 
11.1. Identification of proteins bands 
 
Protein bands from a 12 % SDS-PAGE Coomassie blue stained gel were subjected 
to MALDI-TOF analysis to confirm their identity (Figure 11.1.1). The gel was 
loaded with intracellular and extracellular samples from a methanol shake flask 
fed-batch culture at the indicated time points. The Pichia pastoris X33-IP cells 
were grown in the 10 L glycerol batch and harvested at stationary growth phase (as 
the period defined in Figure 5.1.1 – C) to start the shake flask fed-batch. Lanes 0 h 
in Figure 11.1.1 denotes the sampling time before methanol induction, at batch 
harvest time. Protein bands number 2 and 5 were positively identified, scores 191 
and 149 respectively, as alcohol oxidase (Aox1) from Pichia pastoris 
(syn. Komagataella pastoris), confirming Aox1 derepression after methanol 
induction (Figure 11.1.1). Protein bands number 4 and 6 were identified as an 
ATPase involved in protein import into the ER, also acts as a chaperone to mediate 
protein folding from Komagataella pastoris GS115, scores 85 and 102 
respectively. Their identity was positively confirmed by sequence comparison as 
Kar2 from Komagataella pastoris. Kar2 identity was further confirmed when the 
extracellular fraction lanes of time point 24 h after methanol induction of Figure 
11.1.1 and Figure 5.1.3 – A are compared. In the 12 % SDS-PAGE image, the 
positively identified protein band number 4 lies in the expected molecular weight 
height of ~74 kDa, whereas in the second figure, an anti-HDEL band in the PVDF 
Western blot membrane is observed in the same molecular weight height. 
Furthermore, the anti-HDEL antibody specificity for Kar2 was confirmed by the 
fact that in Figure 11.1.1 lane 96 h of the extracellular fraction after induction two 
prominent bands are seen, Aox1 and Kar2 (74.4 and 74.2 kDa, respectively), 
however when compared to the same time point in the Western blot in Figure 5.1.3 
– A, only one band in this molecular weight height was observed. Protein bands 
number 1 and 3 were identified, scores 202 and 126 respectively, as an ATPase 
involved in protein folding and the response to stress from Komagataella pastoris 
GS115, which was previously identified in the published work of Vanz et al., 2014 
[4], as a heat shock protein/chaperone belonging to the Hsp70 family. These 
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protein bands were assumed to be Ssa3 by comparing their sequences with the Ssa3 
sequence from Saccharomyces cerevisiae. Figure 11.1.1 shows a decrease of Ssa3 
after methanol induction in the intracellular fraction. In the work of Vanz et al. this 
same downregulation after methanol induction was observed, however an increase 
in 2D SDS-PAGE gels of a fragment (~25 kDa) of this protein was reported [4], 
not observed in the 1D SDS-PAGE gels in this thesis.  
 
 
Figure 11.1.1 – 12 % SDS-PAGE Coomassie blue stained gel highlighting the identified 
protein bands. 
Intracellular and extracellular fractions of Pichia pastoris X33-IP 1 % (v/v) methanol induction 
phase in shake flask fed-batch culture. The shake flask culture was started with cells harvested at 
stationary growth phase during the 10 L glycerol batch and sampling was performed at the indicated 
time after methanol induction. MALDI-TOF analysis positively identified protein bands numbers 2 
and 5 as alcohol oxidase (Aox1), 4 and 6 as Kar2, 1 and 3 as Ssa3. All lysate loaded samples were 
normalized at OD600 50 and extracellular fractions were directly applied. The M lane denotes the 
molecular weight marker. 
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12. Appendix IV 
12.1. Bioreactor feedback controlled fed-batches 
 
The bioreactor feedback controlled fed-batches studied in this section were based 
on the application of a modified two-phase fed-batch procedure employed for the 
secretory production of Insulin precursor (IP) [2], originally developed for high-
level intracellular production of Hepatitis B surface antigen (HBsAg) with P. 
Pastoris GS115 [112]. After P. pastoris cells were allowed unlimited growth until 
depletion of all carbon sources during the glycerol batch phase, methanol was 
injected in the bioreactor to the desired final concentration and pump feeding was 
started in order to maintain a constant methanol set-point. The methanol induction 
phase (MIP) consisted of a feedback controlled fed-batch process, where a flame 
ionization detector (FID) was employed, in closed loop with a PID controller 
system, to measure the methanol concentration in the off-gas outlet of the 
bioreactor (for details, refer to Appendix I, section 9.2, Figure 9.2.2).  
 
 
Figure 12.1.1 – Bioreactor FID feedback controlled fed-batches with different methanol 
concentrations.  
After glycerol depletion during batch growth phase, the fed-batch cultures were induced with 
methanol at four different concentrations. Subsequent to initial cellular adaptation to the new 
substrate, methanol concentration was kept constant by a feeding pump controlled by a PID system 
in closed loop with a flame ionization detector (FID).  
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Methanol derepresses the Aox1 promoter and induces the production of secretory 
Insulin precursor. After the end of the growth phase – when all carbon sources 
were depleted and stirring decreases abruptly (DO-spike) - cultivations were 
induced with different methanol concentrations (Table 12.1.1). As sole carbon 
source during the production phase, methanol was fed in sufficient and controlled 
amount and its concentration was kept relatively stable during the entire production 
phase (Figure 12.1.1). The lowest methanol concentration tested (1.7 g/L) was 
under similar conditions to the two-phase fed-batch procedure employed for the 
secretory production of IP [2]. In this condition, the feedback controlled system 
used in this work was able to pump adequate methanol amounts during the entire 
fed-batch with the lowest set-point error (Figure 12.1.1). In the other three 
conditions (3.5, 5.0 and 6.8 g/L methanol), the identical PID controller parameters 
did not present the same performance, initially over pumping methanol, leading to 
higher set-point deviations during the entire fed-batch (Figure 12.1.1). In time, 
however, cells were able to minimize this effect, stabilizing the methanol 
consumption rate and producing secretory Insulin precursor (Table 12.1.1).  
 
Table 12.1.1 – Parameters of Pichia pastoris X33-IP methanol fed-batch cultivations in 5 L 
bioreactor 
Methanol  
concentration 
during production 
phase (g/L)* 
Conversion of methanol 
into IP YIP/MeOH (mg/g)* 
Methanol 
consumption rate 
(g/L.h)* 
IP volumetric 
productivity (mg/L.h)* 
1.7 2.5 2.5 6.3 
3.5 2.3 4.3 9.9 
5.0 4.3 2.5 10.7 
6.8 2.9 2.4 6.9 
*Values employed in parameters calculations were accounted when the highest amount of IP was 
reached. 
 
To compare the parameters of the four Pichia pastoris X33-IP fed-batch 
cultivations Table 12.1.1 is presented. As described for the shake flask fed-batches 
(Figure 5.2.2 – D), biomass production during the feedback controlled bioreactor 
fed-batches remains approximately constant after methanol induction, therefore the 
analysis of cellular specific productivity does not play an important role. The 
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methanol concentration of 6.8 g/L during fed-batch was similar to the conditions 
applied for the high-level intracellular production of Hepatitis B surface antigen 
(HBsAg) with P. pastoris GS115 [112]. Cells were able to consume and convert 
into IP this high methanol amount for about 75 hours after induction, presenting 
foaming afterwards. Since solely under this elevated substrate concentration cells 
presented foaming, it is viable to speculate that the highest methanol concentration 
that the cells can tolerate has been reached. The highest productivity was achieved 
when Pichia pastoris cells were submitted to 5.0 g/L of methanol during the fed-
batch phase. The secretory Insulin precursor producing cells were able to convert 
more efficiently the sole substrate into product, 4.3 mg/g YIP/MeOH (Table 12.1.1). 
Under this condition as well, cells presented the highest IP volumetric productivity, 
in the range of 10.7 mg/L.h. For better comparison between the four fed-batches, a 
plot of IP volumetric productivity vs. methanol concentration was built (Figure 
12.1.2). The relation between both variables allows estimating the best methanol 
concentration for secretory Insulin precursor production in Pichia pastoris X33-IP 
fed-batch cultivations in 5 L bioreactor, which lies around 4.5 g/L. 
 
 
Figure 12.1.2 – Relation between methanol concentration and IP volumetric productivity for 
Pichia pastoris fed-batch cultures.  
Indicated methanol concentrations were kept constant during the entire 5 L bioreactor fed-batch 
culture. Values employed in parameters calculations were accounted when the highest amount of IP 
was reached. 
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13. Appendix V 
13.1. Images employed in the Kar2 relative quantification 
 
 
Figure 13.1.1 – SDS-PAGE and Western blot images of Pichia pastoris X33-IP bioreactor 
batches cultivated under different initial glycerol concentrations. 
Respectively, the exponential phase intracellular fraction SDS-PAGE (12 %) and Western blot 
(anti-HDEL) time course images employed for Kar2 relative quantification from cells cultured 
under different initial glycerol concentrations. Samples were taken at the indicated time points 
during exponential phase of growth. All lysate loaded samples were normalized at OD600 50 and 
extracellular fractions were directly applied. The M lane denotes the molecular weight marker. 
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Figure 13.1.2 – SDS-PAGE and Western blot images of Pichia pastoris X33-IP shake flask fed-
batches induced at different growth times. 
Respectively, the intracellular and extracellular fractions SDS-PAGE (12 %) and Western blot (anti-
HDEL) time course images employed for Kar2 relative quantification from cells harvested at 
exponential growth phase (A) and (B), at declining growth phase (C) and (D), at stationary phase 
(E) and (F). Samples were taken at the indicated time points after the start of methanol feed during 
shake flask fed-batch cultivations. All lysate loaded samples were normalized at OD600 50 and 
extracellular fractions were directly applied. The M lane denotes the molecular weight marker. 
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Figure 13.1.3 – SDS-PAGE and Western blot images of samples from Pichia pastoris X33-IP 
feedback controlled fed-batches. 
Respectively, the intracellular and extracellular fractions SDS-PAGE (12 %) and Western blot (anti-
HDEL) time course images employed for Kar2 relative quantification from feedback controlled fed-
batches under: 1.7 g/L (A), (B), (C) and (D); 5.0 g/L (E), (F), (G) and (H); 6.8 g/L (I), (J), (K) and 
(L) methanol. Samples were taken at the indicated time points after the start of methanol feed during 
bioreactor fed-batch cultivations. The rectangle in the right illustrates the increase on methanol 
concentration from the different conditions tested. All lysate loaded samples were normalized at 
OD600 50 and extracellular fractions were directly applied. The M lane denotes the molecular weight 
marker.  
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14. Appendix VI 
14.1. ROS fluorescence histograms of control experiments 
 
Positive controls indicated that the increase in the red fluorescence intensity for 
propidium iodide (PI) (FL3) was negatively correlated with viable cells, and the 
increase of the green fluorescence intensity for 2′,7′-dichlorfluorescein (DCF) 
(FL1) was positively correlated with intracellular ROS of yeast cells (Figure 14.1.1 
– B and E, respectively). Considering that ROS is mostly generated after methanol 
induction, samples from the glycerol batch phase were employed as negative 
controls. Samples without PI and DCF staining from the glycerol batch were tested 
for cellular autofluorescence (Figure 14.1.1 – A and D). The indicated horizontal 
bar (M1) illustrated in Figure 14.1.1 – B was used to generate a gate area, which 
excludes the heat damaged FL3 fluorescence positive cells, allowing the 
qualification between viable and dead cells. Quantification of ROS was performed 
by the evaluation of the mean FL1 fluorescence signal intensity value for each 
sample incubated with DCF. Evaluation of ROS formation was performed only in 
viable cells through the application of the gated area in all samples. To illustrate the 
ROS and cellular viability quantification procedure Figure 14.1.1 – C and F are 
presented. Samples were double stained with PI and DCF and the fluorescence was 
monitored by the respective filters, FL3 and FL1. Figure 14.1.1 – F exemplifies a 
fluorescence histogram plot from double stained cells, harvested at glycerol 
exponential phase of growth, containing events gated for viable cells plotted 
against the DCF signal intensity (FL1). For this cultivation time point cells were 99 
% viable (Figure 5.2.2 – E), according to the gate generated from the PI positive 
control, and presented a mean FL1 fluorescence signal intensity, which quantifies 
ROS formation, of 1.55 (Figure 5.2.2 – A). Curiously, the mean FL1 fluorescence 
signal intensity obtained for the DCF positive control, where cells were incubated 
for 1 h with 100 µM DTBP, was comparable with those obtained at the end of the 
fed-batch cultivation. 
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Figure 14.1.1 – Flow cytometry fluorescence histograms of control experiments. 
Pichia pastoris cells viability and reactive oxygen species control experiments of (A and D) 
negative control, untreated glycerol batch cells without propidium iodide (PI) and 2′,7′-
dichlorfluorescein (DCF), (B) PI positive control, heat-killed cells, (C and F) untreated glycerol 
batch cells stained with PI and DCF and (E) DCF positive control, DTBP-incubated cells. FL3 
LOG: fluorescence emitted by propidium iodide (PI) staining in logarithmic scale; FL1 LOG: 
fluorescence emitted by 2′,7′-dichlorfluorescein (DCF) staining in logarithmic scale. M1 marks 
the gated area which represents viable cells that have not taken up PI. 
 
 
Appendix VII  96 
15. Appendix VII 
15.1. Materials 
15.1.1. Strains  
 
The Pichia pastoris host strain X-33 and the plasmid pPICZα were purchased from 
Thermo Fisher Scientific, USA. The construction of the P. pastoris host strain X-
33 carrying Insulin precursor gene under the control of the alcohol oxidase 
promoter (PAOX1) and harbouring a Mut+ phenotype used for this study was 
described previously [2].  
 
15.1.2. Chemicals, media components, kits and other consumables  
 
Chemicals and media components used in the present work and their sources are 
listed in Table 15.1.1. Pierce bicinchoninic acid (BCA) protein assay kit was 
obtained from Thermo Fisher Scientific, Germany. Unstained and pre-stained 
protein ladders were obtained from Thermo Fisher Scientific, Germany. The 
Streamline SPXL ion exchange resin was procured from GE Healthcare, USA. 3 
µm SUPELCOSIL™ LC-304 column (3.3 cm × 4.6 mm) for reversed-phase high 
performance liquid chromatography (RP-HPLC) was purchased from Sigma-
Aldrich, Germany. Aminex HPX-87H column for glycerol measurements was 
produced by Bio-Rad Laboratories, USA. Ethanol measurements were performed 
with a Supelcowax 10 column (Sigma-Aldrich, Germany). Dialysis was performed 
with 3 kDa molecular weight cut off Centricon tubes from Merck Millipore, 
Germany. Anti-HDEL (2E7 mouse monoclonal antibody was purchased from Santa 
Cruz Biotechnology, USA. Goat anti-mouse IgG specific peroxidase conjugate was 
produced by Calbiochem, USA. 3,3′,5,5′-Tetramethylbenzidine (TMB) liquid substrate 
system for Western blot detection was obtained from Sigma-Aldrich, Germany. 
Polyvinylidene difluoride (PVDF) membrane for Western blotting was obtained from 
Bio-Rad GmbH, Germany.  
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Table 15.1.1 – List of chemicals used in the present work 
Chemical  Annotation  Manufacturer  
Acetic acid  CH3CO2H 
Carl Roth GmbH + Co. KG., 
Germany 
Acetonitrile  CH3CN  
Carl Roth GmbH + Co. KG., 
Germany 
Acrylamide and 
bisacrylamide stock 
solution  
Rotiphorese® Gel 30 
(37,5:1)  
Carl Roth GmbH + Co. KG., 
Germany 
Agarose  Biozym LE GP agarose  Biozym Scientific GmbH, Germany 
Ammonia solution NH4OH (25%) 
Carl Roth GmbH + Co. KG., 
Germany 
Ammonium hydrogen 
carbonate  
NH4HCO3  Merck KgaA, Germany 
Ammonium persulfate  (NH4)2S2O8  Sigma-Aldrich GmbH,  Germany 
Ammonium sulfate  (NH4)2SO4  
Carl Roth GmbH + Co. KG., 
Germany 
Antifoam Ucolub N115 Fragol GmbH + Co. KG., Germany 
BD FACSFlow Sheath 
Fluid 
 
Becton, Dickinson and Company, 
USA 
D-Biotin C10H16N2O3S Sigma-Aldrich GmbH,  Germany 
Boric acid H3BO3 
Carl Roth GmbH + Co. KG., 
Germany 
Bromophenol Blue  C19H10Br4O5S Sigma-Aldrich GmbH,  Germany 
Calcium chloride 
dehydrate 
CaCl2.2H2O 
Carl Roth GmbH + Co. KG., 
Germany 
2′,7′-
dichlorodihydrofluorescin 
diacetate (DCFH-DA) 
C24H16Cl2O7 Sigma-Aldrich GmbH,  Germany 
Coomassie Blue G250  C47H50N3NaO7S2 Merck KgaA, Germany 
DL-Dithiothreitol (DTT)  C4H10O2S2 Sigma-Aldrich GmbH, Germany 
Ethylenediaminetetraaceti
c acid (EDTA) 
C10H16N2O8 Sigma-Aldrich GmbH, Germany 
Ethanol (96%) C2H6O Merck KGaA , Germany 
Formic acid  HCOOH  J.T.Baker Chemical Company, USA  
D-Glucose C6H12O6 
Carl Roth GmbH + Co. KG., 
Germany 
Glycerol (86% or 99%) C3H8O3 
Carl Roth GmbH + Co. KG., 
Germany 
Glycine  C2H5NO2  
Carl Roth GmbH + Co. KG., 
Germany 
Iodoacetamide  ICH2CONH2  GE Healthcare, United Kingdom 
Iron(III) chloride 
hexahydrate 
FeCl₃.6H2O 
Carl Roth GmbH + Co. KG., 
Germany 
LB medium Luria Bertani (LB) 
Carl Roth GmbH + Co. KG., 
Germany 
Magnesium sulphate 
heptahydrate 
MgSO4·7H2O 
Carl Roth GmbH + Co. KG., 
Germany 
Manganese(II) sulfate MnSO4 
Carl Roth GmbH + Co. KG., 
Germany 
2-Mercaptoethanol C2H6OS Sigma-Aldrich GmbH, Germany 
Methanol  CH3OH  
Carl Roth GmbH + Co. KG., 
Germany 
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Chemical  Annotation  Manufacturer  
Dimethyl sulfoxide 
(DMSO) 
(CH₃)₂SO Sigma-Aldrich GmbH, Germany 
Peptone Bacto™ Proteose Peptones Difco Laboratories Inc., USA 
Phosphoric acid  H3PO4 (85%)  
Carl Roth GmbH + Co. KG., 
Germany 
Potassium chloride KCl 
Carl Roth GmbH + Co. KG., 
Germany 
Potassium iodide KI 
Carl Roth GmbH + Co. KG., 
Germany 
Potassium phosphate 
dibasic  
K2HPO4  
Carl Roth GmbH + Co. KG., 
Germany 
Potassium phosphate 
monobasic  
KH2PO4  
Carl Roth GmbH + Co. KG., 
Germany 
2-Propanol C3H8O 
Carl Roth GmbH + Co. KG., 
Germany 
Propidium iodide C27H34I2N4 Sigma-Aldrich GmbH, Germany 
Polyvinylpyrrolidone (C6H9NO)n Sigma-Aldrich GmbH, Germany 
Silicon M100 
Polydimethyl siloxane 
(C2H6OSi)n 
Carl Roth GmbH + Co. KG., 
Germany 
Skim milk Skim milk 
Becton, Dickinson and Company, 
USA 
Sodium chloride NaCl 
Carl Roth GmbH + Co. KG., 
Germany 
Sodium dodecyl sulphate NaC12H25SO4 
Bio-Rad Laboratories GmbH, 
Germany 
Sodium hydrogen 
phosphate 
NaH2PO4 
Carl Roth GmbH + Co. KG., 
Germany 
Disodium hydrogen 
phosphate 
Na2HPO4 
Carl Roth GmbH + Co. KG., 
Germany 
Sodium hydroxide NaOH 
Carl Roth GmbH + Co. KG., 
Germany 
Sodium molybdate Na₂MoO₄ 
Carl Roth GmbH + Co. KG., 
Germany 
Sulphuric acid H2SO4 
Carl Roth GmbH + Co. KG., 
Germany 
Tetramethylethylenediami
ne (TEMED)  
C6H16N2 Sigma-Aldrich GmbH, Germany  
Trifluoroacetic acid (TFA)  C2HF3O2 Merck KgaA, Germany 
3,3´,5,5´tetramethylbenzid
ine (TMB) 
C16H20N2 Sigma-Aldrich GmbH,  Germany 
Tris(hydroxymethyl)  
aminomethane (Tris)  
C4H11NO3 
Carl Roth GmbH + Co. KG., 
Germany 
Triton X-100 
(polyethylene glycol p-
(1,1,3,3-tetramethylbutyl)-
phenyl ether) 
C14H22O(C2H4O)n  Sigma-Aldrich GmbH, Germany  
Tween 20 (Polysorbate 
20) 
C58H114O26 Sigma-Aldrich GmbH, Germany  
Yeast extract Y.E. 
Bio-Rad Laboratories GmBH, 
Germany 
Yeast nitrogen base w/o 
amino acids and 
(NH4)2SO4 
Y.N.B. 
Becton, Dickinson and Company, 
USA 
Zinc sulphate 
heptahydrate 
ZnSO₄ ·7H2O 
Carl Roth GmbH + Co. KG., 
Germany 
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15.1.3. Equipments and laboratory tools 
 
10 L stirred tank reactor Biostat® C, Sartorius AG, Germany 
2 L stirred tank reactor Biostat® B plus, Sartorius AG, Germany 
5 L stirred tank reactor Biostat® B plus, Sartorius AG, Germany  
Autoclave Systek GmbH, Germany 
Centrifuges 
 
Thermo Fisher Scientific Inc., Germany 
Heraeus Instruments GmbH, Germany 
Clean bench Thermo Fisher Scientific Inc., Germany 
Electroblot semi-dry transfer 
chamber 
Bio-Rad Laboratories GmBH, Germany 
Electrophoresis Chambers  Bio-Rad Laboratories GmBH, Germany 
Flow cytometer Epics XL-MCL, Beckman Coulter Inc., USA 
Gas chromatograph GC-2010 plus, Shimadzu Corp., Japan 
Gas sensors BlueSens GmbH, Germany 
Glassware Schott AG, Germany 
HPLC system Chromaster, Hitachi Inc., USA 
Ice machine Ziegrea Eismachinen GmbH, Germany 
Incubator Infors AG, Switzerland 
 
Microwave 
Certomat® BS-1, Sartorius AG, Germany 
MLS GmbH, Germany 
Osmometer Gonotec GmbH, Germany 
Peristaltic pump SciLog Inc., USA 
Phase contrast microscope Olympus GmbH, Germany 
pH-eletrode, inline Hamilton Messtechnik GmbH, Germany 
pH-meter 
Deutsche Metrohm Gmbh & Co. KG, 
Germany 
Pipette (1000, 200, 100, 20 µL) Eppendorf GmbH, Germany 
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pO2-eletrode, inline Hamilton Messtechnik GmbH, Germany 
Scale Sartorius AG, Germany 
Shake flasks 150 mL, disposable Sigma-Aldrich GmbH,  Germany 
Spectrophotometer Thermo Fisher Scientific Inc., Germany 
Ultrapure water system Sartorius AG, Germany 
Vortex Phoenix, Germany 
  
  
Appendix VII  101 
15.2. List of figures 
 
Figure 1.1 – Fellowship sponsors…………………………………………………12 
Figure 2.2.1 – Amino acid sequences of human, bovine and porcine Insulin. ....... 14 
Figure 2.3.1 – Pichia pastoris X33-IP (A) isolated colonies grown in agar plates 
and (B) In situ microscopy image of high cell density culture in 10 L bioreactor. 16 
Figure 2.4.1 – Schematic representation of protein folding and secretion in ER. 
Modified based on [35]. .......................................................................................... 18 
Figure 2.4.2 – The folding cycle of Kar2, a chaperone belonging to the Hsp70 
family. Figure modified based on [47].................................................................... 23 
Figure 2.4.3 – Diagram representing the protein folding, secretion, UPR and ERAD 
in yeast. Modified based in [73].............................................................................. 24 
Figure 2.6.1 –Oxidative protein folding in the yeast ER diagram. Modified from 
[97]. ......................................................................................................................... 28 
Figure 5.1.1 – Time course analysis of the bioreactor glycerol batch from Pichia 
pastoris X33-IP cells. .............................................................................................. 43 
Figure 5.1.2 – Media osmolarity decreases concomitant to glycerol reduction. .... 44 
Figure 5.1.3 – Monitoring Kar2 in the intracellular and extracellular fractions of 
methanol fed-batch phase in shake flasks of P. pastoris cells harvested at different 
glycerol growth phase and time course analysis of secretory Insulin precursor 
production. .............................................................................................................. 48 
Figure 5.1.4 – Comparison of intracellular and extracellular Kar2 at fed-batch 
methanol induction time. ........................................................................................ 49 
Figure 5.1.5 – Effect of different fed-batch methanol concentrations on intracellular 
and extracellular Kar2 and on secretory Insulin precursor production. .................. 51 
Figure 5.2.1 – ROS, viability and optical density of 4 different Pichia pastoris 
strains. ..................................................................................................................... 54 
Figure 5.2.2 – Methanol shake flask fed-batches time course monitoring and 
comparison of X33-IP cells..................................................................................... 56 
Figure 9.1.1 – Optical density time course comparison of P. pastoris X33-IP grown 
in different inoculum media in shake flasks. .......................................................... 77 
Figure 9.2.1 – Schematic of a closed loop PID feedback controller applied in the 
fed-batches. ............................................................................................................. 79 
Appendix VII  102 
Figure 9.2.2 – Two-phase fed-batch cultivation of P. pastoris X-33 secreting 
Insulin precursor. .................................................................................................... 80 
Figure 9.2.3 – SDS-PAGE time course analysis of Pichia pastoris X33-IP 
intracellular and extracellular fractions after methanol induction. ......................... 81 
Figure 9.2.4 – SDS-PAGE and Western blot glycerol batch phase time course of 
the methanol feedback controlled fed-batch. .......................................................... 81 
Figure 9.3.1 – Streamline SP XL ion exchange FPLC chromatogram and SDS-
PAGE 16 % purification steps. ............................................................................... 82 
Figure 9.4.1 –  Purified Insulin precursor quantification curve by RP-HPLC. ...... 83 
Figure 10.1.1 – Time course analysis of the 95 g/L bioreactor glycerol batch and 
shake flask fed-batch from Pichia pastoris X33 host cells. .................................... 85 
Figure 11.1.1 – 12 % SDS-PAGE Coomassie blue stained gel highlighting the 
identified protein bands. .......................................................................................... 87 
Figure 12.1.1 – Bioreactor FID feedback controlled fed-batches with different 
methanol concentrations. ........................................................................................ 88 
Figure 12.1.2 – Relation between methanol concentration and IP volumetric 
productivity for Pichia pastoris fed-batch cultures. ............................................... 90 
Figure 13.1.1 – SDS-PAGE and Western blot images of Pichia pastoris X33-IP 
bioreactor batches cultivated under different initial glycerol concentrations. ........ 91 
Figure 13.1.2 – SDS-PAGE and Western blot images of Pichia pastoris X33-IP 
shake flask fed-batches induced at different growth times. .................................... 92 
Figure 13.1.3 – SDS-PAGE and Western blot images of samples from Pichia 
pastoris X33-IP feedback controlled fed-batches. .................................................. 93 
Figure 14.1.1 – Flow cytometry fluorescence histograms of control experiments. 95 
 
  
Appendix VII  103 
15.3. List of tables 
 
Table 4.6.1 – Composition of resolving and stacking SDS-PAGE gels ................. 36 
Table 5.1.1 – Comparison of Pichia pastoris batches with different glycerol 
concentrations ......................................................................................................... 45 
Table 12.1.1 – Parameters of Pichia pastoris X33-IP methanol fed-batch 
cultivations in 5 L bioreactor .................................................................................. 89 
Table 15.1.1 – List of chemicals used in the present work ..................................... 97 
 
  
Appendix VII  104 
15.4. Abbreviations 
% Percent 
[Cco2]in Inlet carbon dioxide concentration (%) 
[Cco2]out Outlet carbon dioxide concentration (%) 
[Co2]in Inlet oxygen concentration (%) 
[Co2]out Outlet oxygen concentration (%) 
°C Degrees Celsius 
µ Specific growth rate (h-1) 
µL Microliter 
µm Micrometer 
µmax Maximal specific growth rate (h
-1) 
µs Gly Specific glycerol consumption rate (h
-1) 
aa Amino acid 
AAA 
ATPases associated with diverse cellular 
activities 
ADP Adenosine diphosphate 
Aox1 Alcohol oxidase 1 
AOX1 Alcohol oxidase 1 gene 
Aox2 Alcohol oxidase 2 
AOX2 Alcohol oxidase 2 gene 
ATP Adenosine triphosphate 
bar Unit of pressure 
BCA Bicinchoninic acid protein assay kit 
BiP 
Immunoglobulin heavy chain-binding 
protein (syn. Kar2) 
bp Base pair 
BSA Bovine serum albumin 
Cdc48 Chaperone-like AAA ATPase in yeast 
cm Centimeter 
Cne1 Calnexin homolog in S. cerevisiae 
CO2 Carbon dioxide 
CopI Coat protein complex I 
CopII Coat protein complex II 
CPR Carbon production rate 
Cta Catalase 
Dak Dihydroxyacetone kinase 
Das Dihydroxyacetone synthase 
DCF 2′,7′-dichlorfluorescein 
DCM Dry cell mass (g/L) 
DHA Dihydroxyacetone 
DHAP Dihydroxyacetone phosphate 
DnaJ 
Co-chaperone from E. coli homolog to 
Hsp40 
DnaK Chaperone from E. coli homolog to 
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Hsp70 
DO Dissolved oxygen (%) 
ER Endoplasmic reticulum 
ERAD 
Endoplasmic-reticulum-associated 
protein degradation 
Erd2 
Endoplasmic reticulum retention 
defective, ER membrane protein 
Ero1 Oxidoreductin 1, ER membrane protein 
ERO1 Oxidoreductin 1 gene 
ESR Environmental stress response 
F1,6BP Fructose 1,6-bisphosphate 
F6P Fructose 6-phosphate 
FAD Flavin adenine dinucleotide 
Fdh 
NAD(+)-dependent formate 
dehydrogenase 
Fgh S-formylglutathione hydrolase 
FID Flame ionization detector 
Fin Inlet air flow (L/min) 
Fld Formaldehyde dehydrogenase 
Fout Outlet air flow (L/min) 
FPS1 
Plasma membrane glycerol efflux 
channel 
g Gram 
GAP Glyceraldehyde 3-phosphate 
GC Gas chromatography 
GDP1 Glycerol-3-phosphate dehydrogenase 
Grp78 
Immunoglobulin heavy chain-binding 
protein (syn. Kar2) 
GS-CH2OH S-hydroxymethyl glutathione 
GS-CHO S-formylglutathione 
GSH Reduced form of glutathione 
GSSG Oxidized glutathione 
h Hour 
H2O Water 
Hac1 UPR transcription factor 
HAC1 UPR transcription factor gene 
HDEL 
C-terminal tetrapeptide ER retention 
signal in yeast 
HOG High osmolarity glycerol pathway 
Hsp Heat shock protein 
Hsp110 
Heat shock protein/chaperone family 
110 
Hsp40 Heat shock protein/chaperone family 40 
Hsp60 
Heat shock protein: family 60; 
tetradecameric mitochondrial chaperonin 
Hsp70 Heat shock protein/chaperone family 70 
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Hsp82 Heat shock protein/chaperone family 90 
Hsp90 Heat shock protein/chaperone family 90 
HspA5 
Immunoglobulin heavy chain-binding 
protein (syn. Kar2) 
IgG Immunoglobulin G  
Ire1 
Serine-threonine kinase and 
endoribonuclease, transmembrane 
protein 
Kar2 
Immunoglobulin heavy chain-binding 
protein 
KAR2 
Immunoglobulin heavy chain-binding 
protein gene 
kDa Kilodalton 
KDEL 
C-terminal tetrapeptide ER retention 
signal in mammals 
Kg Kilogram 
L Liter 
mAU Milliabsorbance units 
MFα 
Saccharomyces cerevisiae α-mating 
factor pre-pro-peptide signal leader 
sequence 
min Minute 
mL Milliliter 
mm Millimeter 
MM Molecular mass (g/mol) 
mmol Millinumber of atoms 6.0221415×1023 
mol Number of atoms 6.0221415×1023 
mRNA Messenger RNA 
mS Millisiemens 
Mut- 
Methanol utilization minus P. pastoris 
strain 
Mut+ 
Methanol utilization plus P. pastoris 
strain 
Muts 
Methanol utilization slow P. pastoris 
strain 
NEF Nucleotide exchange factors 
nm Nanometer 
O2 Oxygen 
OD600 Optical density measured at 600 nm 
osmol osmotic active units (in mol) 
OUR Oxygen uptake rate 
PAOX1 Alcohol oxidase promoter 
PBS 
Phosphate buffered saline solution with 
1 % (v/v) Tween 20 
PBS Phosphate buffered saline solution 
PDI Protein disulfide isomerase 
PDI Protein disulfide isomerase gene 
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pH 
pH value, negative log of the activity of 
the hydrogen ion in an aqueous solution 
PI Propidium iodide 
PPI Peptidyl prolyl isomerase 
PVDF Polvinylidene fluoride 
QC Quality control 
Rgl1 Transfer RNA ligase 
ROS Reactive oxygen species 
RP- HPLC 
Reversed-phase high performance liquid 
chromatography 
rpm Rotations per minute 
RQ Respiratory quotient 
SDS-PAGE 
Sodium dodecylsulfate polyacrylamide 
gel electrophoresis 
Sec61 Translocon pore complex 
Ssa3 Heat shock protein/chaperone family 70 
Ssa4 Heat shock protein/chaperone family 70 
Ssb1 Heat shock protein/chaperone family 70 
Sso2 
Plasma membrane t-SNARE involved in 
secretion 
T Temperature 
TEMED 
N, N, N', N'-
Tetramethylethylenediamine 
TMB 3, 3', 5, 5'- Tetramethylbenzidene 
UGGT 
(UDP)-glucose:glycoprotein 
glucosyltransferase 
UPR Unfolded protein response 
v/v Volume per volume 
Vm Ideal gas molecular volume (L/mol) 
VR Bioreactor volume (L) 
vvm 
Volume of medium per volume of air 
(Lmedium/Lair) 
w/v Weight per volume 
w/w Weight per weight 
X33 Pichia pastoris host strain 
X33-IP 
Pichia pastoris secretory Insulin 
precursor producing strain 
Xu5P Xylulose 5-phosphate 
YDCM/Gly 
Conversion of glycerol in biomass 
(gDCM/gGly) 
YNB 
Yeast nitrogen base without amino acids 
and ammonium sulfate 
YTM Yeast trace metal solution 
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